prednisolone has been researched along with Intraocular Pressure in 225 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Intraocular Pressure: The pressure of the fluids in the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This research was performed to compare the effects of prednisolone and fluorometholone on intraocular pressure (IOP) and Schirmer tear test (STT) in the normal equine eye." | 9.69 | Comparison of the Effects of 0.1% Fluorometholone and 1% Prednisolone on Intraocular Pressure and Schirmer Tear Test in Equine Eye. ( Anoushepour, A; Atai, T; Ozmaie, S, 2023) |
| "To compare the efficacy of systemic prednisolone and topical tranexamic acid (TA) on the rate of rebleeding in patients with macroscopic traumatic hyphema (MTH)." | 9.51 | Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial. ( Abbaspour, M; Abrishami, M; Bakhtiari, E; Derakhshan, A; Esmaeili, S; Firoozi, J; Zia, MJ, 2022) |
| "5% with prednisolone acetate suspension (PA) 1% for the treatment of inflammation after cataract surgery in children." | 9.34 | Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children. ( Vittitow, JL; Williams, JI, 2020) |
| "To compare the outcomes of congenital cataract surgery using intraoperative intracameral triamcinolone versus postoperative oral prednisolone to modulate ocular inflammation." | 9.19 | Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. ( Arantes, TE; Nosé, W; Ventura, BV; Ventura, CV; Ventura, LO; Ventura, MC, 2014) |
| "The results indicate that equivalent control of inflammation can be obtained through treatment with loteprednol etabonate or prednisolone acetate after cataract surgery." | 9.17 | Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. ( Holland, EJ; Lane, SS, 2013) |
| "To compare orbital floor triamcinolone acetonide and oral prednisolone in cataract surgery in patients with chronic non-infectious uveitis with regard to visual outcome, postoperative inflammation and macular edema." | 9.14 | Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis. ( Heiligenhaus, A; Heinz, C; Koch, JM; Roesel, M, 2010) |
| "To compare adverse intraocular pressure (IOP) spikes in patients receiving intravitreal triamcinolone acetonide (IVTA) in 2 cohorts: (i) patients who underwent a topical prednisolone acetate trial (PAT) without incurring a short-term IOP rise, and (ii) control patients who did not undergo a PAT." | 9.14 | A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes. ( Gale, J; Hollands, H; Hollands, S; Seif, G, 2010) |
| "To compare the efficacy and ocular adverse effects of topical prednisolone acetate, ketorolac tromethamine, and fluorometholone acetate in reducing inflammation after phacoemulsification." | 9.10 | Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. ( Atchaneeyasakul, LO; Kosrirukvongs, P; Surachatkumtonekul, T; Trinavarat, A, 2003) |
| "Rimexolone 1% ophthalmic suspension is safe and effective for the treatment of uveitis." | 9.08 | Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis. ( Alter, G; Crabb, JL; DeBarge, LR; Feiler, LS; Foster, CS; Friedlaender, MH; Raizman, MB; Santos, CI, 1996) |
| " Patients who were known to react with a rise of intraocular pressure (IOP) to steroids were treated with clobetasone butyrate eye drops in one eye and either prednisolone eye drops (6 patients) or hydrocortisone eye drops (4 patients) in the other eye." | 9.05 | Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure. ( Eilon, LA; Walker, SR; Williamson, J, 1981) |
| "Clobetasone butyrate has been formulated as a new steroid preparation of use in ophthalmology and has been compared with prednisolone phosphate and betamethasone phosphate in the treatment of anterior uveitis." | 9.05 | Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure. ( Eilon, LA; Walker, SR, 1981) |
| "1% betamethasone disodium phosphate in 71 consecutive patients presenting with acute endogenous non-granulomatous uveitis randomly assigned to one of these treatment groups." | 9.05 | Efficacy in anterior uveitis of two known steroids and topical tolmetin. ( Dunne, JA; Gilbert, DJ; Jacobs, N; Morrison, A, 1985) |
| "Using an intracanalicular dexamethasone insert or topical prednisolone following iStent and Hydrus surgery provided similar short-term control of postoperative inflammation." | 8.12 | Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma. ( Akrobetu, D; Guduru, A; Herndon, LW; Jackson, KJ, 2022) |
| "To compare intraocular pressure (IOP) outcomes between 2 common, commercially available corticosteroid drops: difluprednate ophthalmic emulsion 0." | 7.85 | Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension. ( Ernest, P; McBain, M; Mian, SI; Musch, DC; Niziol, LM; Person, E; Tijunelis, MA, 2017) |
| "005% latanoprost on pupil diameter (PD) and intraocular pressure (IOP)." | 7.83 | The effects of 1% prednisolone acetate on pupil diameter and intraocular pressure in healthy dogs treated with 0.005% latanoprost. ( Bdolah-Abram, T; Kahane, N; Ofri, R; Raskansky, H, 2016) |
| "To identify changes in intraocular pressure (IOP) after vitreoretinal surgical procedures in eyes that received either difluprednate ophthalmic emulsion 0." | 7.80 | Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate. ( Connors, DB; Fine, HF; Jeng, KW; Prenner, JL; Roth, D; Wheatley, HM, 2014) |
| "We have previously shown that tissue plasminogen activator (tPA) injected in the vitreous of sheep, reduced or prevented the elevation of the intraocular pressure (IOP) normally produced by the instillation of 1% prednisolone." | 7.80 | Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep. ( Candia, OA; Danias, J; Gerometta, RM, 2014) |
| "To evaluate the effect of a biodegradable microfilm with sustained release of prednisolone acetate (PA) on postoperative wound healing after experimental glaucoma filtration surgery (GFS)." | 7.77 | Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery. ( Ang, M; Foo, S; Venkatraman, SS; Wong, TT; Yan, P; Zhen, M, 2011) |
| "To describe a clinically observed reduction in intraocular pressure (IOP) without increased allograft rejection in known "steroid responders" using loteprednol etabonate 0." | 7.75 | Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation. ( Djalilian, AR; Holland, EJ; Sanderson, JP, 2009) |
| "In this study, patients with optic neuritis were treated with high-dose prednisolone." | 7.74 | Effects of high-dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis. ( Dorner, GT; Fuchsjäger Mayrl, G; Garhöfer, G; Kircher, K; Reitner, A; Resch, H; Schmetterer, L; Weigert, G, 2008) |
| "To evaluate the six-month results of patients treated with intravitreal prednisolone sodium succinate injections for persistent diabetic macular edema." | 7.74 | Intravitreal prednisolone sodium succinate reduces diabetic macular edema without intraocular pressure rise. ( Berendschot, TT; Hardy, E; Hendrikse, F; La Heij, EC; Liem, AT; Lundqvist, IJ, 2007) |
| "The aim of this study was to report a case of cystoid macular edema (CME) in a pseudophakic patient after switching from latanoprost to BAK-free travoprost." | 7.74 | Cystoid macular edema in a pseudophakic patient after switching from latanoprost to BAK-free travoprost. ( Esquenazi, S, 2007) |
| "To report a case of herpes simplex virus reactivation after starting bimatoprost treatment for glaucoma." | 7.71 | Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. ( Kroll, DM; Schuman, JS, 2002) |
| "To investigate the mechanism by which pilocarpine causes increased aqueous humor (AH) flare, hypotony, and miosis in dogs." | 7.70 | Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs. ( Gionfriddo, J; Krohne, SG; Morrison, EA, 1998) |
| "All subjects (healthy volunteers or patients with inflammation or allergy) in all sponsored loteprednol etabonate studies in the United States were evaluated." | 7.70 | Change in intraocular pressure during long-term use of loteprednol etabonate. ( Crockett, RS; Howes, J; Novack, GD; Sherwood, MB, 1998) |
| "We reviewed the records of 12 eyes of ten adult patients with inflammatory glaucoma who underwent trabeculectomy with the adjuvant use of 5-fluorouracil between January 1986 and January 1989." | 7.68 | Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. ( Jabs, DA; Jampel, HD; Quigley, HA, 1990) |
| " Safety included evaluation of adverse events." | 6.82 | Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. ( Gedif, K; Lambert, SR; Markwardt, K; O'Halloran, H; Plager, DA; Roarty, J; VanderVeen, D; Wilson, ME, 2016) |
| "Rimexolone has a low IOP-elevating potential, comparable to that of fluorometholone and less than that of dexamethasone sodium phosphate and prednisolone acetate." | 6.68 | Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids. ( Assil, K; Bartlett, JD; Leibowitz, HM; McQuirter, H; Rich, R; Stewart, R, 1996) |
| "In pediatric cataracts, outcomes were better with PST tricort and the adjunctive I/C tricort compared to postoperative topical prednisolone, for modulating postoperative inflammation." | 5.69 | Comparison of topical steroids versus adjunctive intracameral triamcinolone versus posterior subtenon triamcinolone in pediatric cataract surgery. ( Bhattacharya, S; Pavitra, B; Raina, UK; Ravinesh, K; Thakar, M, 2023) |
| "To compare the efficacy of systemic prednisolone and topical tranexamic acid (TA) on the rate of rebleeding in patients with macroscopic traumatic hyphema (MTH)." | 5.51 | Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial. ( Abbaspour, M; Abrishami, M; Bakhtiari, E; Derakhshan, A; Esmaeili, S; Firoozi, J; Zia, MJ, 2022) |
| "5% with prednisolone acetate suspension (PA) 1% for the treatment of inflammation after cataract surgery in children." | 5.34 | Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children. ( Vittitow, JL; Williams, JI, 2020) |
| "The aim of this study was to investigate the diagnostic value of a topical prednisolone acetate 1% provocative test for steroid-induced ocular hypertension before intravitreal triamcinolone acetonide injection." | 5.34 | The value of prednisolone acetate provocative test before intravitreal triamcinolone acetonide injections. ( Abdullatif, AM; Fouad, HM; Helmy, YAH; Macky, TA; Mansour, K; Saady, AM, 2020) |
| "Patients older than 18 years with intraocular pressure (IOP) of more than 18 mmHg for whom the clinician decided SLT was the appropriately indicated therapy were randomized to 1 of 3 groups in a ratio of 1:1:1 as follows: ketorolac 0." | 5.30 | SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy. ( Albeiruti, E; Fajardo, R; Goldberg, JL; Groth, SL; Loewen, N; Nunez, M; Schuman, JS; Sharpsten, L, 2019) |
| "To compare intraocular pressure (IOP) elevation and graft rejection with loteprednol etabonate 0." | 5.20 | Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial. ( Feng, MT; Price, FW; Price, MO; Scanameo, A, 2015) |
| "To compare the outcomes of congenital cataract surgery using intraoperative intracameral triamcinolone versus postoperative oral prednisolone to modulate ocular inflammation." | 5.19 | Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone. ( Arantes, TE; Nosé, W; Ventura, BV; Ventura, CV; Ventura, LO; Ventura, MC, 2014) |
| "The results indicate that equivalent control of inflammation can be obtained through treatment with loteprednol etabonate or prednisolone acetate after cataract surgery." | 5.17 | Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. ( Holland, EJ; Lane, SS, 2013) |
| "In this high-dose pulsed-therapy regimen, difluprednate reduced inflammation more effectively than prednisolone acetate, resulting in more rapid return of vision." | 5.15 | A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery. ( Donnenfeld, ED; Fiore, J; Gobbo, A; Holland, EJ; Perry, HD; Prince, J; Sandoval, HP; Shull, ER; Solomon, KD, 2011) |
| "To compare orbital floor triamcinolone acetonide and oral prednisolone in cataract surgery in patients with chronic non-infectious uveitis with regard to visual outcome, postoperative inflammation and macular edema." | 5.14 | Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis. ( Heiligenhaus, A; Heinz, C; Koch, JM; Roesel, M, 2010) |
| "To compare adverse intraocular pressure (IOP) spikes in patients receiving intravitreal triamcinolone acetonide (IVTA) in 2 cohorts: (i) patients who underwent a topical prednisolone acetate trial (PAT) without incurring a short-term IOP rise, and (ii) control patients who did not undergo a PAT." | 5.14 | A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes. ( Gale, J; Hollands, H; Hollands, S; Seif, G, 2010) |
| "To compare the efficacy and ocular adverse effects of topical prednisolone acetate, ketorolac tromethamine, and fluorometholone acetate in reducing inflammation after phacoemulsification." | 5.10 | Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. ( Atchaneeyasakul, LO; Kosrirukvongs, P; Surachatkumtonekul, T; Trinavarat, A, 2003) |
| "To determine whether a topical ophthalmic diclofenac sodium formulation containing a proprietary polymeric drug delivery system (ISV-205), when dosed concomitantly with 1% prednisolone acetate, is effective in blocking the intraocular pressure (IOP) response in humans." | 5.10 | Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205. ( Stewart, WC, 2003) |
| " methylprednisolone pulse therapy and oral prednisone are equally effective as initial treatments for thyroid-associated ophthalmopathy where diplopia, proptosis and signs of soft tissue inflammation are concerned." | 5.10 | High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. ( Heufelder, A; Karma, A; Kauppinen-Mäkelin, R; Leinonen, E; Löyttyniemi, E; Salonen, O; Sane, T; Setälä, K; Välimäki, M; Viikari, J, 2002) |
| " Secondary hemorrhage had no statistical association with age, gender, oral prednisolone, size of hyphema, and retinal damage." | 5.09 | An analysis of risk for secondary hemorrhage in traumatic hyphema. ( Jahadi, HR; Rahmani, B; Rajaeefard, A, 1999) |
| "Rimexolone 1% ophthalmic suspension is safe and effective for the treatment of uveitis." | 5.08 | Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis. ( Alter, G; Crabb, JL; DeBarge, LR; Feiler, LS; Foster, CS; Friedlaender, MH; Raizman, MB; Santos, CI, 1996) |
| "In the diclofenac group (n = 14), the preoperative intraocular pressure of 30." | 5.08 | The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C. ( Cate, EA; Dubiner, HB; Kent, AR; Mundorf, TK; Stewart, JA; Stewart, WC; Whitaker, R, 1998) |
| "A randomized, prospective study on 68 eyes of 54 patients with progressive, uncontrolled, noninflammatory open-angle glaucoma showed that eyes that received topical prednisolone 1% had a lower intraocular pressure (IOP) 18 months following trabeculectomy than the eyes that received no prednisolone." | 5.07 | The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma: five-year follow-up study. ( Birbillis, EM; Roth, SM; Spaeth, GL; Starita, RJ; Steinmann, WC, 1991) |
| " Patients who were known to react with a rise of intraocular pressure (IOP) to steroids were treated with clobetasone butyrate eye drops in one eye and either prednisolone eye drops (6 patients) or hydrocortisone eye drops (4 patients) in the other eye." | 5.05 | Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure. ( Eilon, LA; Walker, SR; Williamson, J, 1981) |
| "Clobetasone butyrate, a new corticosteroid with a high topical activity, has been compared with prednisolone phosphate and a placebo in the treatment of inflammation following cataract extraction." | 5.05 | Clinical evaluation of clobetasone butyrate: a comparative study of its effects in postoperative inflammation and on intraocular pressure. ( Bartholomew, RS; Ramsell, TG; Walker, SR, 1980) |
| "Clobetasone butyrate has been formulated as a new steroid preparation of use in ophthalmology and has been compared with prednisolone phosphate and betamethasone phosphate in the treatment of anterior uveitis." | 5.05 | Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure. ( Eilon, LA; Walker, SR, 1981) |
| "1% betamethasone disodium phosphate in 71 consecutive patients presenting with acute endogenous non-granulomatous uveitis randomly assigned to one of these treatment groups." | 5.05 | Efficacy in anterior uveitis of two known steroids and topical tolmetin. ( Dunne, JA; Gilbert, DJ; Jacobs, N; Morrison, A, 1985) |
| "Fifty-four subjects with initial intraocular pressures under 20 mm Hg received a different commercial corticosteroid ester of prednisolone or dexamethasone in each eye for three to six weeks." | 5.04 | Similarity of the intraocular pressure response to different corticosteroid esters when compliance is controlled. ( Goldberg, J; Mindel, JS; Tavitian, HO, 1979) |
| " He was diagnosed as having fibrinoid syndrome and started on topical prednisolone, brimonidine, timolol-dorzolamide, and orally administered acetazolamide." | 4.98 | Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature. ( Hwang, CK; Kim, BJ; Kolomeyer, AM, 2018) |
| "Using an intracanalicular dexamethasone insert or topical prednisolone following iStent and Hydrus surgery provided similar short-term control of postoperative inflammation." | 4.12 | Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma. ( Akrobetu, D; Guduru, A; Herndon, LW; Jackson, KJ, 2022) |
| "To compare the safety and efficacy of topical prednisolone and intracanalicular dexamethasone ophthalmic insert for the prevention of postoperative inflammation after cataract surgery." | 4.12 | Safety and efficacy of topical vs intracanalicular corticosteroids for the prevention of postoperative inflammation after cataract surgery. ( Goodling, K; Lehman, E; Lu, AQ; O'Rourke, T; Pantanelli, SM; Rizk, M; Scott, IU, 2022) |
| "To compare intraocular pressure (IOP) outcomes between 2 common, commercially available corticosteroid drops: difluprednate ophthalmic emulsion 0." | 3.85 | Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension. ( Ernest, P; McBain, M; Mian, SI; Musch, DC; Niziol, LM; Person, E; Tijunelis, MA, 2017) |
| "9% bromfenac (Xibrom™) or a celecoxib-impregnated intraocular lens (celecoxib-IOL) compared with 1% prednisolone acetate (PA) in controlling postoperative inflammation and posterior capsule opacification (PCO)." | 3.81 | Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal. ( Brookshire, HL; English, RV; Gift, BW; Gilger, BC; Nadelstein, B; Weigt, AK, 2015) |
| "Prednisolone, the first-line treatment for children with nephrotic syndrome, causes severe side effects." | 3.80 | Early and frequent development of ocular hypertension in children with nephrotic syndrome. ( Ando, T; Hamada, R; Hamasaki, Y; Hataya, H; Honda, M; Ishikura, K; Kawaguchi, E; Miura, M; Morikawa, Y; Nagaoka, Y; Noda, E; Sakai, T, 2014) |
| "To identify changes in intraocular pressure (IOP) after vitreoretinal surgical procedures in eyes that received either difluprednate ophthalmic emulsion 0." | 3.80 | Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate. ( Connors, DB; Fine, HF; Jeng, KW; Prenner, JL; Roth, D; Wheatley, HM, 2014) |
| "We have previously shown that tissue plasminogen activator (tPA) injected in the vitreous of sheep, reduced or prevented the elevation of the intraocular pressure (IOP) normally produced by the instillation of 1% prednisolone." | 3.80 | Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep. ( Candia, OA; Danias, J; Gerometta, RM, 2014) |
| "To determine whether adverse effects such as elevated intraocular pressure and cataracts, which are lower with dexamethasone when compared with fluocinolone acetonide or triamcinolone acetonide, may be explained in part by the differences in drug lipophilicity and partitioning of these drugs into the trabecular meshwork and lens." | 3.77 | Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts. ( Kadam, R; Kompella, UB; Thakur, A, 2011) |
| "To evaluate the effect of a biodegradable microfilm with sustained release of prednisolone acetate (PA) on postoperative wound healing after experimental glaucoma filtration surgery (GFS)." | 3.77 | Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery. ( Ang, M; Foo, S; Venkatraman, SS; Wong, TT; Yan, P; Zhen, M, 2011) |
| "Intraocular pressure (IOP) was monitored by Perkins applanation tonometry in 16 normal sheep receiving topically administered prednisolone acetate, 0." | 3.76 | Suppression of corticosteroid-induced ocular hypertension in sheep by anecortave. ( Candia, OA; Gerometta, R; Millar, JC; Podos, SM, 2010) |
| "To analyze morphologic changes in the trabecular meshwork (TM) of bovine eyes treated with topical prednisolone and exhibiting elevated intraocular pressure for 4 weeks." | 3.76 | Morphologic changes in the outflow pathways of bovine eyes treated with corticosteroids. ( Candia, O; Danias, J; Gerometta, R; Hammer, CM; Lütjen-Drecoll, E; Podos, SM; Tektas, OY, 2010) |
| " This case with bilateral uveitis, increased intraocular pressure and blurred disc margins may unravel strange ocular complications of the disease and arise awareness of gout while prescribing diuretics and cyclosporine in patients with uveitis and increased intraocular pressure." | 3.75 | Gout attack with unusual ocular complications. ( Cağil, N; Erten, S; Midillioğlu, IK; Orhan, N; Simşek, S; Yülek, F, 2009) |
| "To describe a clinically observed reduction in intraocular pressure (IOP) without increased allograft rejection in known "steroid responders" using loteprednol etabonate 0." | 3.75 | Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation. ( Djalilian, AR; Holland, EJ; Sanderson, JP, 2009) |
| "In this study, patients with optic neuritis were treated with high-dose prednisolone." | 3.74 | Effects of high-dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis. ( Dorner, GT; Fuchsjäger Mayrl, G; Garhöfer, G; Kircher, K; Reitner, A; Resch, H; Schmetterer, L; Weigert, G, 2008) |
| "To evaluate the six-month results of patients treated with intravitreal prednisolone sodium succinate injections for persistent diabetic macular edema." | 3.74 | Intravitreal prednisolone sodium succinate reduces diabetic macular edema without intraocular pressure rise. ( Berendschot, TT; Hardy, E; Hendrikse, F; La Heij, EC; Liem, AT; Lundqvist, IJ, 2007) |
| "In cases where prednisolone acetate was administered, we found a significant correlation between N363S heterozygosity and steroid-induced ocular hypertension." | 3.74 | The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy. ( Bányász, I; Borgulya, G; Filkorn, T; Majnik, J; Nagy, ZZ; Szabó, V, 2007) |
| "The aim of this study was to report a case of cystoid macular edema (CME) in a pseudophakic patient after switching from latanoprost to BAK-free travoprost." | 3.74 | Cystoid macular edema in a pseudophakic patient after switching from latanoprost to BAK-free travoprost. ( Esquenazi, S, 2007) |
| "Intraocular pressure was monitored by Perkins applanation tonometry in a group of 12 cows receiving topically administered prednisolone acetate in 1 eye 3 times a day for a period of 49 days after the establishment of baseline IOP values." | 3.72 | Steroid-induced ocular hypertension in normal cattle. ( Candia, OA; Danias, J; Gerometta, R; Malgor, LA; Mittag, T; Podos, SM; Wu, B, 2004) |
| "To report a case of herpes simplex virus reactivation after starting bimatoprost treatment for glaucoma." | 3.71 | Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. ( Kroll, DM; Schuman, JS, 2002) |
| "To investigate the mechanism by which pilocarpine causes increased aqueous humor (AH) flare, hypotony, and miosis in dogs." | 3.70 | Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs. ( Gionfriddo, J; Krohne, SG; Morrison, EA, 1998) |
| "All subjects (healthy volunteers or patients with inflammation or allergy) in all sponsored loteprednol etabonate studies in the United States were evaluated." | 3.70 | Change in intraocular pressure during long-term use of loteprednol etabonate. ( Crockett, RS; Howes, J; Novack, GD; Sherwood, MB, 1998) |
| " Initial presentation of the patient was bilateral iridocyclitis, for which he was treated with prednisolone acetate 1% every 2 hours for 6 months." | 3.70 | Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. ( Cheng, L; Freeman, WR; Levi, L; Ozerdem, U; Scher, C; Song, MK, 2000) |
| "We reviewed the records of 12 eyes of ten adult patients with inflammatory glaucoma who underwent trabeculectomy with the adjuvant use of 5-fluorouracil between January 1986 and January 1989." | 3.68 | Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. ( Jabs, DA; Jampel, HD; Quigley, HA, 1990) |
| " The X-ray-induced ocular inflammation, particularly the rise in intraocular pressure, was found to be inhibited by intravenous pretreatment of rabbits with flurbiprofen, indomethacin, or imidazole (1, 10, and 100 mg/kg i." | 3.66 | The role of the arachidonic acid cascade in the species-specific X-ray-induced inflammation of the rabbit eye. ( Bito, LZ; Klein, EM, 1982) |
| "0% prednisolone acetate before performing argon laser trabeculoplasty in an attempt to prevent the increase in intraocular pressure frequently observed during the immediate postoperative period." | 3.66 | Effects of corticosteroid pretreatment on argon laser trabeculoplasty. ( Ruderman, JM; Weinreb, RN; Wilensky, JT; Zweig, KO, 1983) |
| "Implants with a regime of fibrosis suppression (prednisolone 30 mg daily plus fluphenamic acid 200 mg three times a day for 6 to 8 weeks) controlled the intraocular pressure (applanation tonometry (AT) less than 21 mm Hg) in seven out of ten patients with different types of glaucoma." | 3.66 | Glaucoma implants. Their use in difficult cases of glaucoma. ( Bartholomew, RS, 1978) |
| "Surgical treatment of large granulomas leads to a more complete and rapid resolution of inflammation." | 2.94 | Anterior chamber granuloma: conservative treatment versus surgical intervention. ( Ahmed, MN; Kamal, MA; Sadek, SH; Youssef, MM, 2020) |
| " The primary outcome was safety, evaluated by the incidence and severity of adverse events." | 2.87 | Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study. ( Donnenfeld, ED; Matossian, C; Solomon, KD, 2018) |
| " Safety included evaluation of adverse events." | 2.82 | Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. ( Gedif, K; Lambert, SR; Markwardt, K; O'Halloran, H; Plager, DA; Roarty, J; VanderVeen, D; Wilson, ME, 2016) |
| "The intraocular pressures were measured at regular intervals during the 6-months follow-up period." | 2.80 | Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty. ( Anctil, JL; Champagne, S; Des Marchais, B; Goyette, A; Lajoie, C, 2015) |
| " Dosing was 4 times daily in months 1 to 3, thrice daily in month 4, twice daily in month 5, and once daily in months 6 to 12." | 2.79 | Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty. ( Bachmann, BO; Kruse, FE; Price, FW; Price, MO; Tourtas, T, 2014) |
| "The intraocular pressure was slightly higher in Group II (p<0." | 2.78 | Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components. ( Avakian, A; Brasil, A; Cunha, PA; Shinzato, FA; Tecchio, GT; Weber, SL, 2013) |
| " Adverse event reports including elevation of intraocular pressure (IOP) were recorded." | 2.77 | Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety. ( Alakuş, MF; Işcan, Y; Oner, V; Taş, M; Türkcü, FM, 2012) |
| " Difluprednate provides effective treatment for anterior uveitis and requires less frequent dosing than prednisolone acetate." | 2.75 | Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. ( Crockett, RS; Davanzo, R; Flynn, TE; Foster, CS; McLeod, K; Vogel, R, 2010) |
| "Intraocular pressure was increased regularly." | 2.69 | Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group. ( , 1999) |
| "In the dosage used, diclofenac was as effective an anti-inflammatory agent for uncomplicated post-cataract inflammation as prednisolone." | 2.68 | A comparison of topical diclofenac with prednisolone for postcataract inflammation. ( Brennan, KM; Roberts, CW, 1995) |
| "Rimexolone has a low IOP-elevating potential, comparable to that of fluorometholone and less than that of dexamethasone sodium phosphate and prednisolone acetate." | 2.68 | Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids. ( Assil, K; Bartlett, JD; Leibowitz, HM; McQuirter, H; Rich, R; Stewart, R, 1996) |
| "The risk of steroid-induced ocular hypertension may depend on age and ethnicity." | 1.62 | Risk of ocular hypertension in children treated with systemic glucocorticoid. ( Albertsen, BK; Glerup, M; Krag, S; Larsen, D, 2021) |
| "Non-infectious endophthalmitis was reported to occur after cataract surgery or intravitreal injections." | 1.39 | Non-infectious endophthalmitis after vitrectomy. ( Cheung, N; Huang, Y; Tian, B; Wei, WB, 2013) |
| "Sodium cyanide can cause severe injuries to the cornea and the anterior segment." | 1.38 | Spontaneous resolution of extensive descemet membrane detachment caused by sodium cyanide injury to the eye. ( Pan, F; Yao, YF; Zhang, B, 2012) |
| " The effect of particle size in the micron and nano-size ranges as well as the effect of viscosity of the nanosuspension on the ocular bioavailability was studied by measuring the intraocular pressure of normotensive Albino rabbits using shiØetz tonometer." | 1.34 | Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. ( Abdel Rahman, AA; Ahmed, MB; Ghorab, MM; Kassem, MA; Khalil, RM, 2007) |
| " The dosage of oral corticosteroids and/or second-line immunosuppressive medication was reduced or stopped altogether in 18 of 33 eyes (54." | 1.33 | Outcome of intravitreal triamcinolone in uveitis. ( Kok, H; Lau, C; Lightman, S; Maycock, N; McCluskey, P, 2005) |
| "A 9-year-old patient with leukemia received oral prednisolone at a dosage of 2." | 1.32 | Intraocular pressure profile of a child on a systemic corticosteroid. ( Chik, KW; Lam, DS; Li, RT; Ng, JS; Tham, CC, 2004) |
| " These values were sustained throughout dosing but declined rapidly to baseline upon cessation of treatment." | 1.30 | Pharmacological validation of a feline model of steroid-induced ocular hypertension. ( Bhattacherjee, P; Graff, G; Paterson, CA; Spellman, JM; Yanni, JM, 1999) |
| "Steroid-induced ocular hypertension is generally attributed to alterations in the trabecular meshwork, reducing aqueous outflow." | 1.29 | Steroid-induced ocular hypertension in the presence of a functioning Molteno seton. ( Brian, G; Muecke, J, 1995) |
| "We report a case of ocular hypotony secondary to a cyclodialysis cleft that developed following a phacoemulsification procedure in which a scleral tunnel incision was used." | 1.29 | Cyclodialysis cleft following a scleral tunnel incision. ( Maffett, MJ; O'Day, DM, 1994) |
| "In 1992 the patient developed Graves' disease followed by endocrine ophthalmopathy class IV 1 year later." | 1.29 | Endocrine ophthalmopathy in a patient under continuous immunosuppressive therapy after cardiac transplantation. ( Baldissera, I; Finkenstedt, G; Höfle, G; Moncayo, R; Pfister, R, 1995) |
| "The intraocular pressure was reduced to about 6 mm Hg in treated eyes from an average pressure of 26 mm Hg." | 1.28 | [Anti-inflammatory treatment after argon laser trabeculoplasty]. ( Bleckmann, H; Garus, HJ; Huk, B, 1991) |
| "In the literature 7 cases of temporal arteritis accompanied by ocular hypotony have been reported." | 1.26 | Acute ocular hypotony. A rare complication of temporal arteritis. ( Bardach, H; Radda, TM; Riss, B, 1981) |
| "Pretreatment with indomethacin did not block the intraocular pressure rise induced by A23187." | 1.26 | The effect of cation ionophores on intraocular pressure. ( Podos, SM, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 66 (29.33) | 18.7374 |
| 1990's | 37 (16.44) | 18.2507 |
| 2000's | 49 (21.78) | 29.6817 |
| 2010's | 57 (25.33) | 24.3611 |
| 2020's | 16 (7.11) | 2.80 |
| Authors | Studies |
|---|---|
| Derakhshan, A | 1 |
| Firoozi, J | 1 |
| Esmaeili, S | 1 |
| Bakhtiari, E | 1 |
| Abbaspour, M | 1 |
| Abrishami, M | 1 |
| Zia, MJ | 1 |
| Jackson, KJ | 1 |
| Akrobetu, D | 1 |
| Guduru, A | 1 |
| Herndon, LW | 1 |
| Lu, AQ | 1 |
| Rizk, M | 1 |
| O'Rourke, T | 1 |
| Goodling, K | 1 |
| Lehman, E | 1 |
| Scott, IU | 1 |
| Pantanelli, SM | 1 |
| Raina, UK | 1 |
| Ravinesh, K | 1 |
| Bhattacharya, S | 1 |
| Pavitra, B | 1 |
| Thakar, M | 1 |
| Sawada, M | 1 |
| Takachi, T | 1 |
| Watanabe, K | 1 |
| Tsuchiya, Y | 1 |
| Nishimura, K | 1 |
| Hotta, Y | 1 |
| Sato, M | 1 |
| Atai, T | 1 |
| Ozmaie, S | 1 |
| Anoushepour, A | 1 |
| Groth, SL | 1 |
| Albeiruti, E | 1 |
| Nunez, M | 1 |
| Fajardo, R | 1 |
| Sharpsten, L | 1 |
| Loewen, N | 1 |
| Schuman, JS | 2 |
| Goldberg, JL | 1 |
| Sheppard, J | 2 |
| Garg, S | 1 |
| Lievens, C | 1 |
| Brandano, L | 1 |
| Wirostko, B | 1 |
| Korenfeld, M | 1 |
| Raizman, M | 2 |
| Foster, CS | 6 |
| Sadek, SH | 1 |
| Ahmed, MN | 1 |
| Kamal, MA | 1 |
| Youssef, MM | 1 |
| Vittitow, JL | 1 |
| Williams, JI | 1 |
| Edwards, RG | 1 |
| Vanderhoof, S | 1 |
| Palestine, A | 1 |
| Seibold, LK | 2 |
| Mandell, KJ | 1 |
| Clark, D | 1 |
| Chu, DS | 1 |
| Brady, TC | 1 |
| Price, MO | 3 |
| Feng, MT | 2 |
| Price, FW | 4 |
| Parab, A | 1 |
| Sivakumar, P | 1 |
| Krag, S | 1 |
| Larsen, D | 1 |
| Albertsen, BK | 1 |
| Glerup, M | 1 |
| Rajendrababu, S | 1 |
| Pallamparthy, S | 1 |
| Arunachalam, A | 1 |
| Uduman, MS | 1 |
| Srinivasan, S | 1 |
| Krishnadas, SR | 1 |
| Senthilkumar, VA | 1 |
| Tijunelis, MA | 1 |
| Person, E | 1 |
| Niziol, LM | 1 |
| Musch, DC | 1 |
| Ernest, P | 1 |
| McBain, M | 1 |
| Mian, SI | 1 |
| Moussa, K | 1 |
| Shantha, J | 1 |
| Schallhorn, JM | 1 |
| Nazarali, S | 1 |
| Cote, SL | 1 |
| Gooi, P | 1 |
| Donnenfeld, ED | 2 |
| Solomon, KD | 2 |
| Matossian, C | 1 |
| Kolomeyer, AM | 1 |
| Hwang, CK | 1 |
| Kim, BJ | 1 |
| Baltinas, J | 1 |
| Weaver, T | 1 |
| McCluskey, P | 2 |
| Zagora, S | 1 |
| Saady, AM | 1 |
| Fouad, HM | 1 |
| Abdullatif, AM | 1 |
| Helmy, YAH | 1 |
| Macky, TA | 1 |
| Mansour, K | 1 |
| Faria-Correia, F | 1 |
| Ramos, I | 1 |
| Valbon, B | 1 |
| Luz, A | 1 |
| Roberts, CJ | 1 |
| Ambrósio, R | 1 |
| Huang, Y | 1 |
| Cheung, N | 1 |
| Tian, B | 1 |
| Wei, WB | 1 |
| Cunha, PA | 1 |
| Shinzato, FA | 1 |
| Tecchio, GT | 1 |
| Weber, SL | 1 |
| Brasil, A | 1 |
| Avakian, A | 1 |
| Gerometta, R | 7 |
| Kumar, S | 2 |
| Shah, S | 1 |
| Alvarez, L | 1 |
| Candia, O | 2 |
| Danias, J | 6 |
| Hedayatfar, A | 1 |
| Hashemi, H | 1 |
| Asgari, S | 1 |
| Chee, SP | 1 |
| Ventura, MC | 1 |
| Ventura, BV | 1 |
| Ventura, CV | 1 |
| Ventura, LO | 1 |
| Arantes, TE | 1 |
| Nosé, W | 1 |
| Brookshire, HL | 1 |
| English, RV | 1 |
| Nadelstein, B | 1 |
| Weigt, AK | 1 |
| Gift, BW | 1 |
| Gilger, BC | 1 |
| Hixson, A | 1 |
| Blanc, S | 1 |
| Sowka, J | 2 |
| Sheppard, JD | 2 |
| Toyos, MM | 1 |
| Kempen, JH | 1 |
| Kaur, P | 1 |
| Kawaguchi, E | 1 |
| Ishikura, K | 1 |
| Hamada, R | 1 |
| Nagaoka, Y | 1 |
| Morikawa, Y | 1 |
| Sakai, T | 1 |
| Hamasaki, Y | 1 |
| Hataya, H | 1 |
| Noda, E | 1 |
| Miura, M | 1 |
| Ando, T | 1 |
| Honda, M | 1 |
| Kruse, FE | 1 |
| Bachmann, BO | 1 |
| Tourtas, T | 1 |
| Jeng, KW | 1 |
| Fine, HF | 1 |
| Wheatley, HM | 1 |
| Roth, D | 1 |
| Connors, DB | 1 |
| Prenner, JL | 1 |
| Jinapriya, D | 1 |
| D'Souza, M | 1 |
| Hollands, H | 2 |
| El-Defrawy, SR | 1 |
| Irrcher, I | 1 |
| Smallman, D | 1 |
| Farmer, JP | 1 |
| Cheung, J | 1 |
| Urton, T | 1 |
| Day, A | 1 |
| Sun, X | 1 |
| Campbell, RJ | 1 |
| Candia, OA | 6 |
| Gerometta, RM | 1 |
| Scanameo, A | 1 |
| Champagne, S | 1 |
| Anctil, JL | 1 |
| Goyette, A | 1 |
| Lajoie, C | 1 |
| Des Marchais, B | 1 |
| Cherof, AM | 1 |
| SooHoo, JR | 1 |
| Kahook, MY | 1 |
| Kahane, N | 1 |
| Bdolah-Abram, T | 1 |
| Raskansky, H | 1 |
| Ofri, R | 1 |
| Gosling, AA | 1 |
| Kiland, JA | 1 |
| Rutkowski, LE | 1 |
| Hoefs, A | 1 |
| Ellinwood, NM | 1 |
| McLellan, GJ | 1 |
| Wilson, ME | 1 |
| O'Halloran, H | 1 |
| VanderVeen, D | 1 |
| Roarty, J | 1 |
| Plager, DA | 1 |
| Markwardt, K | 1 |
| Gedif, K | 1 |
| Lambert, SR | 1 |
| Babu, K | 1 |
| De, C | 1 |
| Sampangi, R | 1 |
| Huang, OS | 1 |
| Mehta, JS | 1 |
| Htoon, HM | 1 |
| Tan, DT | 1 |
| Wong, TT | 2 |
| Kircher, K | 1 |
| Weigert, G | 1 |
| Resch, H | 1 |
| Garhöfer, G | 1 |
| Dorner, GT | 1 |
| Fuchsjäger Mayrl, G | 1 |
| Reitner, A | 1 |
| Schmetterer, L | 1 |
| Roesel, M | 2 |
| Heinz, C | 2 |
| Koch, JM | 2 |
| Heiligenhaus, A | 2 |
| Dhingra, S | 1 |
| Williams, G | 1 |
| Pearson, A | 1 |
| Costa, DC | 1 |
| de Castro, RS | 1 |
| Kara-Jose, N | 1 |
| Podos, SM | 8 |
| Yülek, F | 1 |
| Cağil, N | 1 |
| Orhan, N | 1 |
| Midillioğlu, IK | 1 |
| Erten, S | 1 |
| Simşek, S | 1 |
| Poon, A | 1 |
| Constantinou, M | 1 |
| Lamoureux, E | 1 |
| Taylor, HR | 1 |
| Besada, E | 1 |
| Frauens, BJ | 1 |
| Paganelli, F | 2 |
| Cardillo, JA | 2 |
| Melo, LA | 2 |
| Lucena, DR | 1 |
| Silva, AA | 1 |
| Oliveira, AG | 2 |
| Höfling-Lima, AL | 1 |
| Nguyen, QD | 1 |
| Kuppermann, BD | 1 |
| Belfort, R | 1 |
| Sungur, GK | 1 |
| Hazirolan, D | 1 |
| Yalvac, IS | 1 |
| Ozer, PA | 1 |
| Aslan, BS | 1 |
| Duman, S | 1 |
| Sallam, A | 1 |
| Sheth, HG | 1 |
| Habot-Wilner, Z | 1 |
| Lightman, S | 2 |
| Erdurmus, M | 1 |
| Cohen, EJ | 1 |
| Yildiz, EH | 1 |
| Hammersmith, KM | 1 |
| Laibson, PR | 1 |
| Varssano, D | 1 |
| Rapuano, CJ | 1 |
| Holland, EJ | 3 |
| Djalilian, AR | 1 |
| Sanderson, JP | 1 |
| Spiga, MG | 2 |
| Borrás, T | 2 |
| Nazm, N | 1 |
| Dubey, S | 1 |
| Gandhi, M | 1 |
| Pegu, J | 1 |
| Millar, JC | 1 |
| Kaufman, PL | 1 |
| Tektas, OY | 1 |
| Hammer, CM | 1 |
| Lütjen-Drecoll, E | 1 |
| Holz, H | 1 |
| Pirouzian, A | 1 |
| Davanzo, R | 1 |
| Flynn, TE | 1 |
| McLeod, K | 1 |
| Vogel, R | 1 |
| Crockett, RS | 2 |
| Seif, G | 1 |
| Hollands, S | 1 |
| Gale, J | 1 |
| Chiang, CC | 1 |
| Lin, TH | 1 |
| Tien, PT | 1 |
| Tsai, YY | 1 |
| Mukherji, S | 1 |
| Ramanathan, S | 1 |
| Tarin, S | 1 |
| Thakur, A | 1 |
| Kadam, R | 1 |
| Kompella, UB | 1 |
| Chang, DF | 1 |
| Tan, JJ | 1 |
| Tripodis, Y | 1 |
| Das, S | 1 |
| Sharma, S | 1 |
| Sahu, SK | 1 |
| Vemuganti, GK | 1 |
| Payne, JF | 1 |
| Srivastava, SK | 1 |
| Wells, JR | 1 |
| Grossniklaus, HE | 1 |
| Fiore, J | 1 |
| Gobbo, A | 1 |
| Prince, J | 1 |
| Sandoval, HP | 1 |
| Shull, ER | 1 |
| Perry, HD | 1 |
| Ge, Y | 1 |
| Ren, L | 1 |
| Panagis, L | 1 |
| Mittag, TW | 1 |
| Ang, M | 1 |
| Yan, P | 1 |
| Zhen, M | 1 |
| Foo, S | 1 |
| Venkatraman, SS | 1 |
| Altan-Yaycioglu, R | 1 |
| Canan, H | 1 |
| Akova, YA | 1 |
| Oner, V | 1 |
| Türkcü, FM | 1 |
| Taş, M | 1 |
| Alakuş, MF | 1 |
| Işcan, Y | 1 |
| Zhang, B | 1 |
| Pan, F | 1 |
| Yao, YF | 1 |
| Saffra, N | 1 |
| Smith, SN | 1 |
| Seidman, CJ | 1 |
| Koktekir, BE | 1 |
| Gedik, S | 1 |
| Bakbak, B | 1 |
| Tokuda, N | 1 |
| Inoue, J | 1 |
| Yamazaki, I | 1 |
| Matsuzawa, A | 1 |
| Munemasa, Y | 1 |
| Kitaoka, Y | 1 |
| Takagi, H | 1 |
| Ueno, S | 1 |
| Lane, SS | 1 |
| Hirukawa, K | 1 |
| Keino, H | 1 |
| Watanabe, T | 1 |
| Okada, AA | 1 |
| Park, JJ | 1 |
| Gole, GA | 1 |
| Trinavarat, A | 1 |
| Atchaneeyasakul, LO | 1 |
| Surachatkumtonekul, T | 1 |
| Kosrirukvongs, P | 1 |
| LINNER, E | 1 |
| BECKER, B | 6 |
| MILLS, DW | 1 |
| MILLER, D | 1 |
| PECZON, JD | 1 |
| WHITWORTH, CG | 1 |
| Stewart, WC | 3 |
| Tham, CC | 2 |
| Ng, JS | 1 |
| Li, RT | 1 |
| Chik, KW | 1 |
| Lam, DS | 3 |
| Cheng, AC | 1 |
| Law, RW | 1 |
| Young, AL | 1 |
| Becker, HI | 1 |
| Walton, RC | 1 |
| Diamant, JI | 1 |
| Zegans, ME | 1 |
| Wu, B | 1 |
| Malgor, LA | 1 |
| Mittag, T | 1 |
| Vollmer, L | 1 |
| Falco, L | 1 |
| Skaf, M | 1 |
| Costa, RA | 1 |
| Samudre, SS | 1 |
| Lattanzio, FA | 1 |
| Williams, PB | 1 |
| Hirneiss, C | 1 |
| Neubauer, AS | 1 |
| Kampik, A | 1 |
| Schönfeld, CL | 1 |
| Biswas, J | 1 |
| Ganeshbabu, TM | 1 |
| Raghavendran, SR | 1 |
| Raizada, S | 1 |
| Mondkar, SV | 1 |
| Madhavan, HN | 1 |
| McLeod, SD | 1 |
| Mather, R | 1 |
| Hwang, DG | 1 |
| Margolis, TP | 1 |
| Satav, SS | 1 |
| Thomas, R | 1 |
| Kahana, A | 1 |
| Kok, H | 1 |
| Lau, C | 1 |
| Maycock, N | 1 |
| Nessim, M | 1 |
| Kyprianou, I | 1 |
| Kumar, V | 1 |
| Murray, PI | 1 |
| Kurian, M | 1 |
| Shetty, R | 1 |
| Shetty, BK | 1 |
| Devi, SA | 1 |
| La Heij, EC | 1 |
| Lundqvist, IJ | 1 |
| Berendschot, TT | 1 |
| Hardy, E | 1 |
| Liem, AT | 1 |
| Hendrikse, F | 1 |
| Frucht-Pery, J | 1 |
| Landau, D | 1 |
| Raiskup, F | 1 |
| Orucov, F | 1 |
| Strassman, E | 1 |
| Blumenthal, EZ | 1 |
| Solomon, A | 1 |
| Szabó, V | 1 |
| Borgulya, G | 1 |
| Filkorn, T | 1 |
| Majnik, J | 1 |
| Bányász, I | 1 |
| Nagy, ZZ | 1 |
| Kassem, MA | 1 |
| Abdel Rahman, AA | 1 |
| Ghorab, MM | 1 |
| Ahmed, MB | 1 |
| Khalil, RM | 1 |
| Mittal, A | 1 |
| Mittal, S | 1 |
| Bharathi, JM | 1 |
| Ramakrishnan, R | 1 |
| Sathe, PS | 1 |
| Esquenazi, S | 1 |
| Chawla, B | 1 |
| Agarwal, P | 1 |
| Tandon, R | 1 |
| Titiyal, JS | 1 |
| Leung, DY | 1 |
| Li, FC | 1 |
| Kwong, YY | 1 |
| Chiu, TY | 1 |
| Fan, DS | 1 |
| Gupta, SK | 1 |
| Agarwal, R | 1 |
| Galpalli, ND | 1 |
| Srivastava, S | 1 |
| Agrawal, SS | 1 |
| Saxena, R | 1 |
| Tuovinen, E | 1 |
| Esilä, R | 1 |
| Liesmaa, M | 1 |
| Wood, DC | 1 |
| Contaxis, I | 1 |
| Sweet, D | 1 |
| Smith, JC | 1 |
| Van Dolah, J | 1 |
| Williamson, J | 1 |
| Eilon, LA | 2 |
| Walker, SR | 3 |
| Bito, LZ | 1 |
| Klein, EM | 1 |
| Ruderman, JM | 1 |
| Zweig, KO | 1 |
| Wilensky, JT | 1 |
| Weinreb, RN | 1 |
| Kushner, BJ | 1 |
| Sondheimer, S | 1 |
| Ramsell, TG | 2 |
| Bartholomew, RS | 2 |
| Wilhelmus, KR | 1 |
| Falcon, MG | 1 |
| Jones, BR | 1 |
| Radda, TM | 1 |
| Bardach, H | 1 |
| Riss, B | 1 |
| Green, K | 1 |
| Elijah, D | 1 |
| Szymański, J | 1 |
| Hałatek, R | 1 |
| Mazanek-Szymańska, E | 1 |
| Szaflik, J | 1 |
| Muecke, J | 1 |
| Brian, G | 1 |
| Roberts, CW | 1 |
| Brennan, KM | 1 |
| Gwin, TD | 1 |
| Gwynn, DR | 1 |
| Matsunami, C | 1 |
| Hilton, AF | 1 |
| Dyer, JA | 1 |
| Rumbach, OW | 1 |
| Hardie, IR | 1 |
| Maffett, MJ | 1 |
| O'Day, DM | 1 |
| Bartlett, JD | 3 |
| Horwitz, B | 1 |
| Laibovitz, R | 1 |
| Howes, JF | 1 |
| Woolley, TW | 1 |
| Adams, CM | 1 |
| Kong, L | 1 |
| Zhang, C | 1 |
| Chen, M | 1 |
| Xue, G | 1 |
| Alter, G | 1 |
| DeBarge, LR | 1 |
| Raizman, MB | 1 |
| Crabb, JL | 1 |
| Santos, CI | 1 |
| Feiler, LS | 1 |
| Friedlaender, MH | 1 |
| Leibowitz, HM | 1 |
| Rich, R | 1 |
| McQuirter, H | 1 |
| Stewart, R | 1 |
| Assil, K | 1 |
| Höfle, G | 1 |
| Moncayo, R | 1 |
| Baldissera, I | 1 |
| Pfister, R | 1 |
| Finkenstedt, G | 1 |
| Dugel, PU | 1 |
| Heuer, DK | 1 |
| Thach, AB | 1 |
| Baerveldt, G | 1 |
| Lee, PP | 1 |
| Lloyd, MA | 1 |
| Minckler, DS | 1 |
| Green, RL | 1 |
| Araujo, SV | 1 |
| Spaeth, GL | 4 |
| Roth, SM | 2 |
| Starita, RJ | 3 |
| BenEzra, D | 1 |
| Wysenbeek, YS | 1 |
| Cohen, E | 1 |
| Fineman, MS | 1 |
| Emerick, G | 1 |
| Dudley, D | 1 |
| Katz, LJ | 1 |
| Maguire, JI | 1 |
| Krohne, SG | 1 |
| Gionfriddo, J | 1 |
| Morrison, EA | 1 |
| el-Harazi, SM | 1 |
| Ruiz, RS | 1 |
| Feldman, RM | 1 |
| Villanueva, G | 1 |
| Chuang, AZ | 1 |
| Kent, AR | 1 |
| Dubiner, HB | 1 |
| Whitaker, R | 1 |
| Mundorf, TK | 1 |
| Stewart, JA | 1 |
| Cate, EA | 1 |
| Fechtner, RD | 1 |
| Khouri, AS | 1 |
| Zimmerman, TJ | 1 |
| Bullock, J | 1 |
| Feldman, R | 1 |
| Kulkarni, P | 1 |
| Michael, AJ | 1 |
| Realini, T | 1 |
| Warwar, R | 1 |
| Burnstein, Y | 1 |
| Shelton, K | 1 |
| Higginbotham, EJ | 1 |
| Novack, GD | 1 |
| Howes, J | 1 |
| Sherwood, MB | 1 |
| Aras, C | 1 |
| Ozdamar, A | 1 |
| Aktunç, R | 1 |
| Erçikan, C | 1 |
| Rahmani, B | 1 |
| Jahadi, HR | 1 |
| Rajaeefard, A | 1 |
| Välimäki, J | 1 |
| Airaksinen, PJ | 1 |
| Tuulonen, A | 1 |
| Risteli, J | 1 |
| Bhattacherjee, P | 1 |
| Paterson, CA | 1 |
| Spellman, JM | 1 |
| Graff, G | 1 |
| Yanni, JM | 1 |
| Halpern, MT | 1 |
| Palmer, CS | 1 |
| Foster, S | 1 |
| Pal, A | 1 |
| Battista, C | 1 |
| Esmaeli-Gutstein, B | 1 |
| Winkelman, JZ | 1 |
| Goela, A | 1 |
| Damji, KF | 1 |
| Daneshvar, H | 1 |
| Gilberg, SM | 1 |
| Najman-Vainer, J | 1 |
| Smith, RJ | 1 |
| Maloney, RK | 1 |
| Ozerdem, U | 1 |
| Levi, L | 1 |
| Cheng, L | 1 |
| Song, MK | 1 |
| Scher, C | 1 |
| Freeman, WR | 1 |
| Salmon, JF | 1 |
| Ursell, PG | 1 |
| Frith, P | 1 |
| Caprioli, J | 1 |
| Samson, CM | 1 |
| Araie, M | 1 |
| Rockwood, EJ | 1 |
| Willes, L | 1 |
| Price, M | 1 |
| Lyng, A | 1 |
| Ries, J | 1 |
| Noda, Y | 1 |
| Nakazawa, M | 1 |
| Takahashi, D | 1 |
| Tsuruya, T | 1 |
| Saito, M | 1 |
| Sekine, M | 1 |
| Shaikh, NM | 1 |
| Shaikh, S | 1 |
| Singh, K | 1 |
| Manche, E | 1 |
| Kroll, DM | 1 |
| Kauppinen-Mäkelin, R | 1 |
| Karma, A | 1 |
| Leinonen, E | 1 |
| Löyttyniemi, E | 1 |
| Salonen, O | 1 |
| Sane, T | 1 |
| Setälä, K | 1 |
| Viikari, J | 1 |
| Heufelder, A | 1 |
| Välimäki, M | 1 |
| Kopsa, H | 1 |
| Bettelheim, H | 1 |
| Grabner, G | 1 |
| Schmidt, P | 1 |
| Zazgornik, J | 1 |
| Balcke, P | 1 |
| Pils, P | 1 |
| Mindel, JS | 1 |
| Goldberg, J | 1 |
| Tavitian, HO | 1 |
| Rodrigues, MM | 1 |
| Weinreb, S | 1 |
| Belousova, ZF | 1 |
| McEntyre, JM | 1 |
| Palmberg, F | 1 |
| Shin, DH | 1 |
| Yaguchi, S | 1 |
| Polland, W | 1 |
| Thorburn, W | 1 |
| Bigger, JF | 4 |
| Palmberg, PF | 5 |
| Zink, HA | 4 |
| Cantrill, HL | 1 |
| Waltman, SR | 1 |
| Kintanar, GC | 1 |
| Tripathi, RC | 2 |
| Kipp, MA | 1 |
| Tripathi, BJ | 1 |
| Kirschner, BS | 1 |
| Borisuth, NS | 1 |
| Shevell, SK | 1 |
| Ernest, JT | 1 |
| Dziezyc, J | 1 |
| Millichamp, NJ | 1 |
| Rohde, BH | 1 |
| Smith, WB | 1 |
| Huk, B | 1 |
| Garus, HJ | 1 |
| Bleckmann, H | 1 |
| Birbillis, EM | 1 |
| Steinmann, WC | 1 |
| Huige, WM | 1 |
| Beekhuis, WH | 1 |
| Rijneveld, WJ | 1 |
| Schrage, N | 1 |
| Remeijer, L | 1 |
| Jampel, HD | 1 |
| Jabs, DA | 1 |
| Quigley, HA | 1 |
| Kahaly, G | 1 |
| Lieb, W | 1 |
| Müller-Forell, W | 1 |
| Mainberger, M | 1 |
| Beyer, J | 1 |
| Vollmar, J | 1 |
| Staiger, C | 1 |
| Kumar, A | 1 |
| Verma, L | 1 |
| Khosla, PK | 1 |
| Tewari, HK | 1 |
| Jha, SN | 1 |
| van Hees, CL | 1 |
| van Delft, JL | 1 |
| Sterk, CC | 1 |
| van Haeringen, NJ | 1 |
| Oosterhuis, JA | 1 |
| Robin, JB | 1 |
| Steigner, JB | 1 |
| Kaufman, HE | 1 |
| Durham, DG | 1 |
| Gills, JP | 1 |
| Dunne, JA | 1 |
| Jacobs, N | 1 |
| Morrison, A | 1 |
| Gilbert, DJ | 1 |
| Fellman, RL | 1 |
| Poryzees, EM | 1 |
| Greenidge, KC | 1 |
| Traverso, CE | 1 |
| Mendelsohn, AD | 1 |
| Jampol, LM | 1 |
| Shoch, D | 1 |
| Algvere, P | 1 |
| Almqvist, S | 1 |
| Backlund, EO | 1 |
| Prus-Sawicka, K | 3 |
| Lavergne, G | 1 |
| Winand, R | 1 |
| Goldschmidt, E | 1 |
| Lochte, J | 1 |
| Hayreh, SS | 1 |
| Unger, WG | 1 |
| Perkins, ES | 1 |
| Bass, MS | 1 |
| Johnston, SS | 1 |
| Ware, CF | 1 |
| Davies, EW | 1 |
| Sanders, MD | 2 |
| Harry, J | 1 |
| Wilson, DM | 1 |
| Martin, JH | 1 |
| Niall, JF | 1 |
| Levenson, JE | 1 |
| Brightbill, FS | 1 |
| Berkowitz, JS | 1 |
| David, DS | 1 |
| Sakai, S | 1 |
| Shoji, H | 1 |
| Cheigh, JS | 1 |
| Riggio, RR | 1 |
| Stenzel, KH | 1 |
| Rubin, AL | 1 |
| Gnad, HD | 1 |
| Martenet, AC | 1 |
| Hamilton, AM | 1 |
| Garner, A | 1 |
| Horven, I | 1 |
| Schwartz, B | 1 |
| Gi, S | 1 |
| Motegi, T | 1 |
| Sato, N | 1 |
| Miller, SJ | 1 |
| Trillwood, W | 1 |
| Draper, G | 1 |
| Hiller, H | 1 |
| Gupta, SD | 1 |
| Gupta, JS | 1 |
| Gupta, SB | 1 |
| Younessian, S | 1 |
| Psilas, K | 1 |
| Fairbairn, WD | 1 |
| Thorson, JC | 1 |
| Sheklakov, ND | 1 |
| Khurgina, TM | 1 |
| Draeger, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis[NCT02406209] | Phase 2 | 45 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| Randomized, Double-masked, Placebo-controlled Evaluation of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation[NCT03248037] | Phase 3 | 120 participants (Actual) | Interventional | 2017-09-05 | Completed | ||
| A Phase 3 Multicenter, Randomized, Double-Masked Study of the Safety and Efficacy of Difluprednate 0.05% Ophthalmic Emulsion Compared to Prednisolone Acetate 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis[NCT01201798] | Phase 3 | 111 participants (Actual) | Interventional | 2010-10-31 | Completed | ||
| Prospective Analysis of Loteprednol Etabonate Ophthalmic Suspension 0.25% for Prevention of Immunologic Rejection After Descemet Membrane Endothelial Keratoplasty[NCT05136443] | Phase 4 | 71 participants (Actual) | Interventional | 2021-11-23 | Completed | ||
| Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty[NCT01448213] | Phase 2 | 264 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| Prospective, Randomized Comparison of Corticosteroid Dosing Regimens Following Endothelial Keratoplasty[NCT01853696] | Phase 4 | 167 participants (Actual) | Interventional | 2013-03-31 | Completed | ||
| Phase I/II Comparative Study of a Single Intraoperative Sub-Tenon's Capsule Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System Versus 1% Prednisolone and 0.3% Ciprofloxacin Eyedrops for Cataract Surgery[NCT00431028] | Phase 1/Phase 2 | 140 participants (Actual) | Interventional | 2005-09-30 | Terminated (stopped due to Terminated) | ||
| Comparison of Two Different Acrylate Intraocular Lenses in Cataract Surgery in Patients With Non-infectious Uveitis[NCT00403832] | 60 participants | Interventional | 2005-08-31 | Completed | |||
| [NCT00501579] | Phase 3 | 0 participants | Interventional | Completed | |||
| A Randomized, Masked Multi-center Safety & Efficacy Study of the Effects of Preoperative & Postoperative Cataract Surgery Use of Difluprednate Ophthalmic Emulsion, 0.05% Compared to Prednisolone Acetate Ophthalmic Suspension 1% on Visual Acuity & Corneal [NCT01244334] | Phase 4 | 52 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| Multi-Center, Randomized, Phase II/III Clinical Trial to Study the Effects of Preservative-Free Triamcinolone Acetonide as an Adjunct to Photodynamic Therapy in Participants With Neovascular Age-Related Macular Degeneration[NCT00100009] | Phase 3 | 30 participants | Interventional | 2004-12-09 | Completed | ||
| The Effect of Inhaled Corticosteroids on Intraocular Pressure in Patients With Ocular Hypertension or Controlled Glaucoma.[NCT02338362] | Phase 4 | 22 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
| A Comparison of a Single Orbital Floor Injection of Triamcinolone Versus Conventional Steroid and Antibiotic Drops Used Post Operatively in Uneventful Phacoemulsification Surgery[NCT00789971] | 150 participants (Actual) | Interventional | 2007-03-31 | Completed | |||
| A Prospective, Multi-center, Controlled, Double-blind Study to Evaluate the Efficacy and Tolerability of a Steroid/Antibiotic Associated Treatment Following Cataract Extraction by Means of Phaco-emulsification[NCT02973880] | Phase 3 | 180 participants (Actual) | Interventional | 2017-10-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Change from baseline comparison of NS2 ophthalmic drops (0.5%), NS2 (0.5%) and Pred Forte® (0.1%) ophthalmic drops, and Pred Forte® (1%) ophthalmic drops on an anterior chamber cell grade scale of 0 to 4 (0 = absent, 4 = severe). The least squares mean (standard error) was derived from analysis of covariance (ANCOVA) with baseline as a covariate and treatment group as a factor. (NCT02406209)
Timeframe: The efficacy assessment period was assessed at Week 8; baseline was Day 1.
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| NS2 Ophthalmic Drops (0.5%) | -0.7 |
| NS2 (0.5%) and Pred Forte® (0.1%) Ophthalmic Drops | -0.9 |
| Pred Forte® (1%) Ophthalmic Drops | -0.5 |
Intraocular pressure measurement exceeding 24 mm Hg or more than 10 mm Hg greater than the pre-randomization reading. (NCT03248037)
Timeframe: from date of randomization until the date of first documented intraocular pressure elevation exceeding defined threshold up to 9 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Netarsudil | 11 |
| Placebo | 18 |
Lack of efficacy was defined as those subjects who discontinued study participation either due to treatment failure or an adverse event with a preferred term of iridocyclitis, iritis, uveitis, or vitritis. Proportion is reported as percentage of subjects. (NCT01201798)
Timeframe: Time to Event
| Intervention | Percentage of subjects (Number) |
|---|---|
| Durezol | 0 |
| Pred Forte | 14.9 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = ≤ 1 cell count; 1 = 2 to 10 cell count; 2 = 11 to 20 cell count; 3 = 21 to 50 cell count; and 4 = > 50 cell count. (NCT01201798)
Timeframe: Baseline (Day 0), Day 3, Day 7, Day 21, Day 28, Day 35, Day 42
| Intervention | Units on a scale (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline (Day 0) | Day 3 | Day 7 | Day 21 | Day 28 | Day 35 | Day 42 | |
| Durezol | 2.6 | -1.1 | -1.8 | -2.4 | -2.3 | -2.3 | -2.3 |
| Pred Forte | 2.6 | -1.0 | -1.6 | -2.1 | -2.1 | -2.1 | -2.1 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = ≤ 1 cell count; 1 = 2 to 10 cell count; 2 = 11 to 20 cell count; 3 = 21 to 50 cell count; and 4 = > 50 cell count. (NCT01201798)
Timeframe: Baseline (Day 0), Day 14
| Intervention | Units on a scale (Mean) | |
|---|---|---|
| Baseline (Day 0) | Day 14 | |
| Durezol | 2.6 | -2.2 |
| Pred Forte | 2.6 | -2.0 |
Anterior chamber flare (protein escaping from dialated vessels) was assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = none; 1 = mild (trace to clearly noticeable, visible); 2 = moderate; 3 = marked; and 4 = severe. (NCT01201798)
Timeframe: Baseline (Day 0), Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
| Intervention | Units on a scale (Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline (Day 0) | Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| Durezol | 2.2 | -1.1 | -1.6 | -2.0 | -2.0 | -2.0 | -2.0 | -2.0 |
| Pred Forte | 2.3 | -1.2 | -1.6 | -1.9 | -2.0 | -2.0 | -2.0 | -2.0 |
The following signs were each graded on a 0 - 3 scale (0 = absent; 1 = mild; 2 = moderate; 3 = severe): posterior synechia, hypopyon, limbal injection, and keratic precipitates. Peripheral synechia was graded by the combined number of clock hours affected (0 = absent; 1 = < 3 hrs; 2 = 3-6 hours; 3 = > 6 hours). The total sign score was calculated as the sum of the 5 individual sign scores, the anterior chamber cell grade and the anterior chamber flare grade. The minimum/best total sign score was 0, and the maximum/worst total sign score was 23. (NCT01201798)
Timeframe: Baseline (Day 0), Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
| Intervention | Units on a scale (Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline (Day 0) | Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| Durezol | 7.1 | -3.5 | -5.2 | -6.1 | -6.5 | -6.4 | -6.3 | -6.2 |
| Pred Forte | 7.3 | -3.6 | -5.0 | -5.8 | -6.2 | -6.2 | -6.2 | -6.3 |
The following symptoms were each graded by the subject according to a 0-100 visual analog scale (VAS) using a mark on a 100 mm line (0 = absent, 100 = maximal): eye pain, photophobia, blurred vision, and lacrimation. The total symptom score was calculated as the sum of the 4 individual symptom scores. (NCT01201798)
Timeframe: Baseline (Day 0), Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
| Intervention | Units on a scale (Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline (Day 0) | Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| Durezol | 186.7 | -88.4 | -108.2 | -133.3 | -138.8 | -140.1 | -143.9 | -146.2 |
| Pred Forte | 203.2 | -88.4 | -123.8 | -137.4 | -149.5 | -152.4 | -147.3 | -155.5 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and recorded based on actual cell count. Anterior chamber flare (protein escaping from dialated vessels) was assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = none; 1 = mild (trace to clearly noticeable, visible); 2 = moderate; 3 = marked; and 4 = severe. Proportion is reported as percentage of subjects. (NCT01201798)
Timeframe: Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
| Intervention | Percentage of subjects (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| Durezol | 13.0 | 41.3 | 78.3 | 82.6 | 80.4 | 82.6 | 80.4 |
| Pred Forte | 14.9 | 40.4 | 61.7 | 76.6 | 76.6 | 76.6 | 78.7 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and recorded based on actual cell count. Proportion is reported as a percentage of subjects. (NCT01201798)
Timeframe: Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
| Intervention | Percentage of subjects (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| Durezol | 13.0 | 21.7 | 52.2 | 73.9 | 73.9 | 69.6 | 69.6 |
| Pred Forte | 2.1 | 21.3 | 38.3 | 48.9 | 63.8 | 63.8 | 68.1 |
As assessed by the investigator during slit lamp examination. Anterior chamber cell grade was graded on a 5-point scale, with 0 = no cells; 1 = 1 to 10 cells; 2 = 11 to 20 cells; 3 = 21 to 50 cells; and 4 = more than 50 cells. Proportion is reported as percentage of subjects. (NCT01201798)
Timeframe: Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
| Intervention | Percentage of subjects (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| Durezol | 50.0 | 87.0 | 93.5 | 93.5 | 93.5 | 93.5 | 91.3 |
| Pred Forte | 57.4 | 80.9 | 85.1 | 89.4 | 87.2 | 85.1 | 85.1 |
Inflammatory cells in the anterior chamber were assessed by the investigator during slit lamp examination and graded on a 5-point scale, with 0 = ≤ 1 cell count; 1 = 2 to 10 cell count; 2 = 11 to 20 cell count; 3 = 21 to 50 cell count; and 4 = > 50 cell count. Proportion is reported as percentage of subjects. (NCT01201798)
Timeframe: Day 3, Day 7, Day 14, Day 21, Day 28, Day 35, Day 42
| Intervention | Percentage of subjects (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Day 3 | Day 7 | Day 14 | Day 21 | Day 28 | Day 35 | Day 42 | |
| Durezol | 15.2 | 34.8 | 65.2 | 84.8 | 80.4 | 78.3 | 76.1 |
| Pred Forte | 6.4 | 25.5 | 55.3 | 63.8 | 70.2 | 70.2 | 74.5 |
(NCT01448213)
Timeframe: Within 1 year
| Intervention | eyes (Number) |
|---|---|
| Fluorometholone 0.1% Solution | 2 |
| Prednisolone Acetate 1% Solution | 0 |
Absolute IOP greater than or equal to 24 mm Hg or a relative increase of 10 mm Hg over the baseline preoperative reading. (NCT01448213)
Timeframe: one day, two days, one week, one month, 3 months, 6 months and 12 months after DMEK
| Intervention | eyes (Number) |
|---|---|
| Fluorometholone 0.1% Solution | 9 |
| Prednisolone Acetate 1% Solution | 32 |
Rejection episodes were assessed by slit lamp examination and categorized as definite when an endothelial rejection line was detected in a previously clear graft, probable when inflammation (stromal infiltrate, keratic precipitates, cells in the anterior chamber, or ciliary injection) was detected in a previously clear graft without an endothelial rejection line, and possible if central corneal pachymetry increased by 30 microns or more, even if the cornea was clear and no inflammation was detected by slit lamp examination. (NCT01853696)
Timeframe: within first year after cornea transplantation
| Intervention | eyes (Number) |
|---|---|
| Loteprednol | 0 |
| Prednisolone Acetate | 0 |
Number of eyes in which the absolute intraocular pressure equaled or exceeded 24 mm Hg OR in which there was a relative increase of at least 10 mm Hg over the baseline preoperative reading. (NCT01853696)
Timeframe: from 1 to 12 months after transplant
| Intervention | eyes (Number) |
|---|---|
| Loteprednol | 11 |
| Prednisolone Acetate | 27 |
Adherence was calculated from self-reported study diaries and correlated to a counter that measured number of inhaled puffs built into the placebo metered-dose inhalers (NCT02338362)
Timeframe: Completion of study, up to 6 weeks
| Intervention | percentage of required doses (Mean) |
|---|---|
| Fluticasone | 93.6 |
| Saline Placebo | 96.1 |
Masked assessment of intraocular pressure using goldmann application tonometry. Mean of 2 measurements within 1 mmHg will be recorded. (NCT02338362)
Timeframe: week 6
| Intervention | mmHg (Mean) |
|---|---|
| Fluticasone | 14.7 |
| Saline Placebo | 14.8 |
best corrected logMAR visual acuity for each eye. 20/20 vision corresponds with a logMAR score of 0, while negative logMAR scores indicate better than 20/20 vision, values > 0.5 correspond with low vision, and values > 1.3 correspond with blindness. (NCT02338362)
Timeframe: week 6
| Intervention | logMAR (Mean) |
|---|---|
| Fluticasone | 0.15 |
| Saline Placebo | 0.15 |
Participants with 2 consecutive intraocular pressure measurements exceeding 20% increase from baseline were discontinued from study. (NCT02338362)
Timeframe: within 6-week observation period
| Intervention | participants (Number) | |
|---|---|---|
| elevation >20% | no elevation >20% | |
| Fluticasone | 1 | 9 |
| Saline Placebo | 0 | 10 |
subjective (reported) and objective (slit lamp examination) side-effects attributable to study medications (NCT02338362)
Timeframe: from baseline to week 6
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| lens opacity | throat discomfort | headache | difficulty sleeping | no adverse effects | |
| Fluticasone | 0 | 1 | 1 | 0 | 8 |
| Saline Placebo | 0 | 1 | 0 | 1 | 8 |
4 reviews available for prednisolone and Intraocular Pressure
| Article | Year |
|---|---|
Bilateral Secondary Angle Closure During Daratumumab Infusion: A Case Report and Review of the Literature.
Topics: Administration, Ophthalmic; Amyloidosis; Antibodies, Monoclonal; Antineoplastic Agents; Choroidal Ef | 2020 |
Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature.
Topics: Adenine; Administration, Topical; Aged; Anterior Chamber; Antihypertensive Agents; Antineoplastic Ag | 2018 |
Corticosteroid therapy of eye disease. Fifty years later.
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Dexamethasone; Eye Diseases; Fluorometholone; Hu | 1996 |
The response of ocular pressure to corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aqueous Humor; Betamethasone; Cortisone; Dexametha | 1966 |
62 trials available for prednisolone and Intraocular Pressure
| Article | Year |
|---|---|
Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial.
Topics: Antifibrinolytic Agents; Eye Injuries; Humans; Hyphema; Intraocular Pressure; Prednisolone; Tranexam | 2022 |
Comparison of topical steroids versus adjunctive intracameral triamcinolone versus posterior subtenon triamcinolone in pediatric cataract surgery.
Topics: Cataract; Child; Child, Preschool; Eye Diseases; Glucocorticoids; Humans; Inflammation; Intraocular | 2023 |
Comparison of the Effects of 0.1% Fluorometholone and 1% Prednisolone on Intraocular Pressure and Schirmer Tear Test in Equine Eye.
Topics: Animals; Female; Fluorometholone; Horses; Intraocular Pressure; Ophthalmic Solutions; Prednisolone; | 2023 |
SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy.
Topics: Administration, Ophthalmic; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Fema | 2019 |
Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Cell Count | 2020 |
Anterior chamber granuloma: conservative treatment versus surgical intervention.
Topics: Adolescent; Anterior Chamber; Conservative Treatment; Female; Filtering Surgery; Follow-Up Studies; | 2020 |
Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.
Topics: Androstadienes; Cataract; Child; Double-Blind Method; Humans; Inflammation; Intraocular Pressure; Lo | 2020 |
Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement.
Topics: Adult; Aged; Aminoquinolines; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intraocula | 2020 |
Randomized, Double-Masked Trial of Netarsudil 0.02% Ophthalmic Solution for Prevention of Corticosteroid-Induced Ocular Hypertension.
Topics: Adult; Aged; Aged, 80 and over; Benzoates; beta-Alanine; Double-Blind Method; Female; Follow-Up Stud | 2021 |
Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study.
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anterior Chamber; Dexamethasone; Drug De | 2018 |
The value of prednisolone acetate provocative test before intravitreal triamcinolone acetonide injections.
Topics: Administration, Ophthalmic; Adult; Aged; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; | 2020 |
Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Double-Blind Method | 2013 |
Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment of acute anterior uveitis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Cornea; Double-Blind Method; Eyelids; Fem | 2014 |
Outcomes of congenital cataract surgery: intraoperative intracameral triamcinolone injection versus postoperative oral prednisolone.
Topics: Administration, Oral; Anterior Eye Segment; Cataract; Cataract Extraction; Cornea; Corneal Pachymetr | 2014 |
Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anterior Chamber; Anti-Inflammator | 2014 |
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; | 2014 |
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; | 2014 |
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; | 2014 |
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss; | 2014 |
Anti-inflammatory therapy after selective laser trabeculoplasty: a randomized, double-masked, placebo-controlled clinical trial.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents; Cross-Sectional Studies; Do | 2014 |
Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Corneal Endothelial Cell Loss; Descemet Stripp | 2015 |
Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Corneal Endothelial Cell Loss; Descemet Stripp | 2015 |
Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Corneal Endothelial Cell Loss; Descemet Stripp | 2015 |
Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Corneal Endothelial Cell Loss; Descemet Stripp | 2015 |
Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clonidine; Combined Modalit | 2015 |
Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.
Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Animals; Cat Diseases; Cats; Cohort Studies; De | 2016 |
Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
Topics: Administration, Topical; Aphakia, Postcataract; Cataract; Cataract Extraction; Child, Preschool; Dou | 2016 |
Cataract surgery in uveitis.
Topics: Administration, Oral; Anterior Chamber; Cataract; Combined Modality Therapy; Fluorescein Angiography | 2008 |
Case-control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection.
Topics: Case-Control Studies; Corneal Transplantation; Drug Therapy, Combination; Follow-Up Studies; Glucoco | 2009 |
Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial.
Topics: Acute Disease; Administration, Topical; Adult; Aged; Aged, 80 and over; Corneal Transplantation; Cyc | 2008 |
A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery.
Topics: Aged; Anterior Chamber; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Connective T | 2009 |
Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis.
Topics: Administration, Oral; Anterior Chamber; Cataract; Female; Fluorescein Angiography; Glucocorticoids; | 2010 |
Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.
Topics: Adult; Anterior Chamber; Anti-Inflammatory Agents; Emulsions; Female; Fluprednisolone; Glucocorticoi | 2010 |
A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes.
Topics: Administration, Topical; Aged; Choroidal Neovascularization; Follow-Up Studies; Glucocorticoids; Hum | 2010 |
A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.
Topics: Aged; Aged, 80 and over; Cell Count; Cornea; Corneal Edema; Double-Blind Method; Endothelium, Cornea | 2011 |
Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety.
Topics: Administration, Topical; Adolescent; Adult; Allergens; Androstadienes; Anti-Allergic Agents; Conjunc | 2012 |
Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Anterior Chamber; Anti-Allergic Agents; Anti-Inflamm | 2013 |
Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification.
Topics: Administration, Topical; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents; Chi-Square Dis | 2003 |
Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; D | 2003 |
A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.
Topics: Aged; Aged, 80 and over; Connective Tissue; Double-Blind Method; Female; Glucocorticoids; Humans; In | 2004 |
Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; | 2005 |
Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis--a randomized triple masked study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Double-Blind Meth | 2004 |
Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure.
Topics: Acute Disease; Aged; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-C | 2008 |
Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Clinical Trials as Topic; C | 1981 |
Clinical evaluation of clobetasone butyrate: a comparative study of its effects in postoperative inflammation and on intraocular pressure.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Cataract Extraction; Clinica | 1980 |
Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure.
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Dexamethasone; Double- | 1981 |
A comparison of topical diclofenac with prednisolone for postcataract inflammation.
Topics: Administration, Topical; Anterior Chamber; Cataract Extraction; Cell Count; Diclofenac; Double-Blind | 1995 |
Intraocular pressure response to loteprednol etabonate in known steroid responders.
Topics: Adolescent; Adult; Aged; Androstadienes; Anti-Inflammatory Agents; Double-Blind Method; Drug Adminis | 1993 |
Identification of high intraocular pressure responders to topical ophthalmic corticosteroids.
Topics: Adult; Circadian Rhythm; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Ag | 1993 |
Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber | 1996 |
Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Cross-Over Studies; Dexamethasone; D | 1996 |
A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glaucoma, Angle- | 1995 |
A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; C | 1998 |
The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemotherapy, Adjuvant; Chr | 1998 |
The effects of topical steroids on refractive outcome and corneal haze, thickness, and curvature after photorefractive keratectomy with a 6.0-mm ablation diameter.
Topics: Administration, Topical; Adult; Cornea; Corneal Topography; Double-Blind Method; Female; Glucocortic | 1998 |
An analysis of risk for secondary hemorrhage in traumatic hyphema.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifibrinolytic Agents; Child; Child, Preschool; Eye | 1999 |
Postoperative systemic corticosteroid treatment and Molteno implant surgery: a randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Drug Administration Schedule; Female; Filtering Surge | 1999 |
Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Inflammatory Agents; | 1999 |
A prospective, randomized comparison of the use versus non-use of topical corticosteroids after laser in situ keratomileusis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Astigmatism; Cornea; Double-Blind Method; | 2001 |
High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy.
Topics: Administration, Oral; Adult; Aged; Diplopia; Exophthalmos; Female; Glucocorticoids; Graves Disease; | 2002 |
Similarity of the intraocular pressure response to different corticosteroid esters when compliance is controlled.
Topics: Acetates; Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Dexamethasone; | 1979 |
Comparison of prednisolone and RMI-1068 in the ocular irritative response in dogs.
Topics: Animals; Aqueous Humor; Cyclooxygenase Inhibitors; Dogs; Double-Blind Method; Endophthalmitis; Femal | 1992 |
The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma: five-year follow-up study.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, Open-A | 1991 |
Ciamexone in endocrine orbitopathy. A randomized double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Adult; Aged; Aziridines; Double-Blind Method; Female; Humans; Intraocular Pr | 1990 |
Efficacy in anterior uveitis of two known steroids and topical tolmetin.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical | 1985 |
Short- and long-term effects of postoperative corticosteroids on trabeculectomy.
Topics: Adult; Aged; Combined Modality Therapy; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure | 1985 |
Increased sensitivity to theophylline associated with primary open-angle glaucoma.
Topics: Clinical Trials as Topic; Cyclic AMP; Dexamethasone; DNA; Dose-Response Relationship, Drug; Drug Hyp | 1973 |
Effects of prednisolone eye drops. A trial of the effects of prednisolone phosphate eye drops on the intra-ocular pressure of normal volunteers.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Clinical Trials | 1967 |
159 other studies available for prednisolone and Intraocular Pressure
| Article | Year |
|---|---|
Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma.
Topics: Dexamethasone; Glaucoma; Humans; Inflammation; Intraocular Pressure; Macular Edema; Prednisolone | 2022 |
Safety and efficacy of topical vs intracanalicular corticosteroids for the prevention of postoperative inflammation after cataract surgery.
Topics: Adrenal Cortex Hormones; Cataract; Dexamethasone; Humans; Inflammation; Intraocular Pressure; Ophtha | 2022 |
Steroid-induced ocular hypertensive response in pediatric patients with acute lymphoblastic leukemia.
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Female; Glaucoma; Glucocorticoids; Humans; Intraoc | 2023 |
A Rare Case of Pulseless Retinopathy.
Topics: Administration, Oral; Arteriovenous Anastomosis; Carotid Stenosis; Combined Modality Therapy; Female | 2020 |
Risk of ocular hypertension in children treated with systemic glucocorticoid.
Topics: Adolescent; Child; Child, Preschool; Denmark; Dexamethasone; Dose-Response Relationship, Drug; Femal | 2021 |
Incidence and risk factors for postoperative intraocular pressure response to topical prednisolone eye drops in patients undergoing phacoemulsification.
Topics: Aged; Humans; Incidence; Intraocular Pressure; Middle Aged; Ocular Hypertension; Ophthalmic Solution | 2021 |
Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension.
Topics: Cataract Extraction; Fluprednisolone; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Ocul | 2017 |
Blurry Vision and Eye Pain After Pterygium Surgery.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Eye Infe | 2018 |
Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) in Postpenetrating Keratoplasty Steroid-induced Glaucoma: A Case Report.
Topics: Adult; Follow-Up Studies; Glaucoma, Open-Angle; Glucocorticoids; Gonioscopy; Humans; Intraocular Pre | 2018 |
Infective conjunctivitis progressing to posterior scleritis.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Anti-Bacterial Agents; Anti-Inflammatory Agents, | 2019 |
Scheimpflug-based tomography and biomechanical assessment in pressure-induced stromal keratopathy.
Topics: Antihypertensive Agents; Biomechanical Phenomena; Corneal Diseases; Corneal Pachymetry; Corneal Stro | 2013 |
Non-infectious endophthalmitis after vitrectomy.
Topics: Adult; Aged; Dexamethasone; Endophthalmitis; Female; Humans; Intraocular Pressure; Male; Middle Aged | 2013 |
Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator.
Topics: Animals; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Female; Fibr | 2013 |
Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Celecoxib; Cyclooxyg | 2015 |
Monitoring keratitis resolution with optical coherence tomography.
Topics: Adult; Corneal Edema; Corneal Pachymetry; Corneal Stroma; Drug Therapy, Combination; Glucocorticoids | 2014 |
Early and frequent development of ocular hypertension in children with nephrotic syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Antihypertensive Agents; Child; C | 2014 |
Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate.
Topics: Emulsions; Female; Fluprednisolone; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Male; | 2014 |
Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep.
Topics: Animals; Anterior Chamber; Disease Models, Animal; Glucocorticoids; Intraocular Pressure; Ocular Hyp | 2014 |
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation.
Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endop | 2016 |
The effects of 1% prednisolone acetate on pupil diameter and intraocular pressure in healthy dogs treated with 0.005% latanoprost.
Topics: Animals; Antihypertensive Agents; Dogs; Intraocular Pressure; Latanoprost; Mydriatics; Ophthalmic So | 2016 |
Bilateral Outer Retinal Necrosis Following Mumps Infection.
Topics: Acyclovir; Administration, Ophthalmic; Antibodies, Viral; Antiviral Agents; Atrophy; Child; Enzyme-L | 2018 |
Incidence and Risk Factors of Elevated Intraocular Pressure Following Deep Anterior Lamellar Keratoplasty.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Corneal Transplantation; Cyclosporine; Dexamethasone | 2016 |
Effects of high-dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis.
Topics: Acute Disease; Adult; Blood Flow Velocity; Blood Pressure; Female; Glucocorticoids; Humans; Infusion | 2008 |
Severe, permanent orbital disease in herpes zoster ophthalmicus.
Topics: Acyclovir; Antiviral Agents; Blepharoptosis; Conjunctival Diseases; Drug Therapy, Combination; Edema | 2008 |
Steroid-induced ocular hypertension in normal sheep.
Topics: Administration, Topical; Animals; Disease Models, Animal; Glucocorticoids; Intraocular Pressure; Ocu | 2009 |
Gout attack with unusual ocular complications.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Colchicine; Cyclosporine; Diuretics; Edema; Gout; Go | 2009 |
Unilateral granulomatous post-streptococcal uveitis with elevated tension.
Topics: Adolescent; Anti-Inflammatory Agents; Antistreptolysin; Female; Granuloma; Humans; Intraocular Press | 2008 |
Incidence and prognosis of ocular hypertension secondary to viral uveitis.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; F | 2010 |
Traumatic interface oedema two years after LASIK.
Topics: Acetazolamide; Adult; Anterior Eye Segment; Anti-Inflammatory Agents; Antihypertensive Agents; Diure | 2009 |
Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Chronic Disease; Female; Gla | 2009 |
Steroid-induced intraocular pressure elevation or glaucoma after penetrating keratoplasty in patients with keratoconus or Fuchs dystrophy.
Topics: Adolescent; Adult; Aged; Androstadienes; Female; Fluorometholone; Fuchs' Endothelial Dystrophy; Glau | 2009 |
Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Inflammato | 2009 |
Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus.
Topics: Adenoviridae; Animals; Anterior Chamber; Disease Models, Animal; Female; Gene Expression Regulation, | 2010 |
Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.
Topics: Adenoviridae; Adolescent; Aged; Blotting, Western; Cells, Cultured; Child, Preschool; Collagen; Dexa | 2010 |
Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Topics: Acute Disease; Antihypertensive Agents; Chronic Disease; Glaucoma; Glucocorticoids; Humans; Intraocu | 2010 |
Suppression of corticosteroid-induced ocular hypertension in sheep by anecortave.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Aqueous Humor; Disease Models, Animal; Fe | 2010 |
Suppression and reduction of corticosteroid-induced ocular hypertension by anecortave in sheep.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Glucocorticoids; Intraocular Pressure; Ocu | 2010 |
Morphologic changes in the outflow pathways of bovine eyes treated with corticosteroids.
Topics: Administration, Topical; Animals; Cattle; Collagen Type VI; Extracellular Matrix; Female; Glucocorti | 2010 |
Bilateral diffuse lamellar keratitis following consecutive selective laser trabeculoplasty in LASIK patient.
Topics: Functional Laterality; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Keratitis; Keratomileusis | 2010 |
Atypical presentation of cytomegalovirus endotheliitis: a case report.
Topics: Acyclovir; Aged; Antiviral Agents; Corneal Edema; Cytomegalovirus; Cytomegalovirus Infections; DNA, | 2011 |
Uveal effusion associated with Campylobacter jejuni infection presenting as bilateral angle closure glaucoma.
Topics: Acute Disease; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Choroid Diseas | 2011 |
Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts.
Topics: Animals; Budesonide; Cataract; Cattle; Chromatography, High Pressure Liquid; Dexamethasone; Fluocino | 2011 |
Risk factors for steroid response among cataract patients.
Topics: Administration, Topical; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Axial Length, Eye; | 2011 |
Intraocular invasion by microsporidial spores in a case of stromal keratitis.
Topics: Acyclovir; Adult; Biguanides; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Endothelium, | 2011 |
Rosai-Dorfman disease simulating nodular scleritis and panuveitis.
Topics: Diagnosis, Differential; Female; Histiocytes; Histiocytosis, Sinus; Humans; Immunoenzyme Techniques; | 2011 |
Gene expression changes in steroid-induced IOP elevation in bovine trabecular meshwork.
Topics: Animals; Anti-Inflammatory Agents; Cattle; Computational Biology; Disease Models, Animal; Female; Ge | 2011 |
Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery.
Topics: Animals; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Endophthalmitis; Female | 2011 |
Recurrent iris cyst discharge.
Topics: Administration, Topical; Cysts; Exfoliation Syndrome; Female; Glucocorticoids; Humans; Intraocular P | 2012 |
Spontaneous resolution of extensive descemet membrane detachment caused by sodium cyanide injury to the eye.
Topics: Burns, Chemical; Descemet Membrane; Eye Burns; Humans; Intraocular Pressure; Male; Microscopy, Acous | 2012 |
Topiramate-induced refractive change and angle closure glaucoma and its ultrasound bimicroscopy findings.
Topics: Administration, Oral; Administration, Topical; Adult; Anticonvulsants; Female; Fructose; Glaucoma, A | 2012 |
Bilateral severe anterior uveitis after unilateral selective laser trabeculoplasty.
Topics: Adult; Anterior Chamber; Cyclopentolate; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Gl | 2013 |
[Effects of selective laser trabeculoplasty treatment in steroid-induced glaucoma].
Topics: Adolescent; Adult; Betamethasone; Child; Female; Glaucoma; Humans; Intraocular Pressure; Laser Thera | 2012 |
Enhanced depth imaging optical coherence tomography of the choroid in new-onset acute posterior scleritis.
Topics: Acute Disease; Aged; Atrophy; Choroid; Choroid Diseases; Female; Glucocorticoids; Humans; Intraocula | 2013 |
Corticosteroid-induced glaucoma in a child after a scleral reinforcement procedure.
Topics: Child; Dilatation, Pathologic; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Male; Myopia | 2002 |
The effect of prednisolone on aqueous humor dynamics.
Topics: Aqueous Humor; Eye Diseases; Intraocular Pressure; Prednisolone; Tonometry, Ocular | 1957 |
ELEVATED INTRAOCULAR PRESSURE FOLLOWING CORTICOSTEROID EYE DROPS.
Topics: Adrenal Cortex Hormones; Betamethasone; Dexamethasone; Eye Diseases; Glaucoma; Humans; Intraocular P | 1963 |
ELEVATED INTRAOCULAR PRESSURE FOLLOWING CORTICOSTEROID EYE DROPS.
Topics: Adrenal Cortex Hormones; Betamethasone; Dexamethasone; Eye Diseases; Glaucoma; Humans; Intraocular P | 1963 |
ELEVATED INTRAOCULAR PRESSURE FOLLOWING CORTICOSTEROID EYE DROPS.
Topics: Adrenal Cortex Hormones; Betamethasone; Dexamethasone; Eye Diseases; Glaucoma; Humans; Intraocular P | 1963 |
ELEVATED INTRAOCULAR PRESSURE FOLLOWING CORTICOSTEROID EYE DROPS.
Topics: Adrenal Cortex Hormones; Betamethasone; Dexamethasone; Eye Diseases; Glaucoma; Humans; Intraocular P | 1963 |
CORTICOSTEROIDS AND FUNCTIONS IN THE ANTERIOR SEGMENT OF THE EYE.
Topics: Accommodation, Ocular; Administration, Topical; Adrenal Cortex Hormones; Aqueous Humor; Cornea; Dexa | 1965 |
Intraocular pressure profile of a child on a systemic corticosteroid.
Topics: Administration, Oral; Child; Female; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertens | 2004 |
In vivo confocal microscopic findings in patients with steroid-induced glaucoma after LASIK.
Topics: Adult; Cornea; Female; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Keratitis; Keratomil | 2004 |
Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Con | 2004 |
Steroid-induced ocular hypertension in normal cattle.
Topics: Animals; Cattle; Disease Models, Animal; Female; Glucocorticoids; Intraocular Pressure; Ocular Hyper | 2004 |
Rapid onset phacolysis.
Topics: Autoantibodies; Autoantigens; Cataract; Cataract Extraction; Crystallins; Female; Glaucoma; Glucocor | 2004 |
Comparison of topical steroids for acute anterior uveitis.
Topics: Acute Disease; Administration, Topical; Androstadienes; Animals; Aqueous Humor; Blotting, Western; C | 2004 |
Uveitis-associated flap edema and lamellar interface fluid collection after LASIK.
Topics: Acute Disease; Body Fluids; Corneal Edema; Corneal Stroma; Female; Glucocorticoids; Humans; Hyperopi | 2005 |
Preventing steroid-induced glaucoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Glaucoma, Open-Angle; Glucocorticoids; Humans; | 2005 |
Prevention of steroid-induced intraocular pressure elevation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cytoskeletal Proteins; Diclofenac; Drug Delivery Systems; E | 2005 |
Outcome of intravitreal triamcinolone in uveitis.
Topics: Adolescent; Adult; Aged; Cataract; Chronic Disease; Glucocorticoids; Humans; Injections; Intraocular | 2005 |
Anterior scleritis, scleral thinning, and intraocular pressure measurement.
Topics: Anti-Inflammatory Agents; Disease Progression; Drug Therapy, Combination; Female; Flurbiprofen; Huma | 2005 |
In vivo confocal microscopic findings of interlamellar stromal keratopathy induced by elevated intraocular pressure.
Topics: Acetazolamide; Adult; Antihypertensive Agents; Corneal Diseases; Corneal Stroma; Drug Therapy, Combi | 2006 |
Intravitreal prednisolone sodium succinate reduces diabetic macular edema without intraocular pressure rise.
Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocu | 2007 |
Early transient visual acuity loss after LASIK due to steroid-induced elevation of intraocular pressure.
Topics: Adult; Corneal Topography; Female; Glucocorticoids; Humans; Intraocular Pressure; Keratomileusis, La | 2007 |
The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy.
Topics: Adult; Corneal Surgery, Laser; Female; Fluorometholone; Genetic Predisposition to Disease; Genetic V | 2007 |
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
Topics: Administration, Topical; Animals; Biological Availability; Chemistry, Pharmaceutical; Dexamethasone; | 2007 |
Uveitis during outbreak of Chikungunya fever.
Topics: Adult; Aged; Alphavirus Infections; Antihypertensive Agents; Chikungunya virus; Cyclopentolate; Dise | 2007 |
Cystoid macular edema in a pseudophakic patient after switching from latanoprost to BAK-free travoprost.
Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Brimonidine Tartrate; Cloprostenol; Fema | 2007 |
Peripheral ulcerative keratitis with bilateral optic nerve involvement as an initial presentation of acute lymphocytic leukemia in an adult.
Topics: Adult; Corneal Ulcer; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Humans; Int | 2009 |
Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
Topics: Adrenal Cortex Hormones; Animals; Anterior Chamber; Cholinergic Agonists; Conjunctival Diseases; Dis | 2007 |
The influence of corticosteroids on intraocular pressure in rabbits. I. The influence of massive intramuscular doses of cortisone and prednisolone.
Topics: Animals; Cortisone; Injections, Intramuscular; Intraocular Pressure; Prednisolone; Rabbits; Tonometr | 1966 |
Response of rabbits to corticosteroids. I. Influence on growth, intraocular pressure and lens transparency.
Topics: Adrenal Glands; Animals; Body Weight; Cataract; Cortisone; Dexamethasone; Growth; Hydrocortisone; In | 1967 |
The role of the arachidonic acid cascade in the species-specific X-ray-induced inflammation of the rabbit eye.
Topics: Animals; Arachidonic Acids; Cromolyn Sodium; Endophthalmitis; Eye; Female; Flurbiprofen; Imidazoles; | 1982 |
Effects of corticosteroid pretreatment on argon laser trabeculoplasty.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Female; Glaucoma, | 1983 |
Medical treatment of glaucoma associated with cicatricial retinopathy of prematurity.
Topics: Acetazolamide; Child; Child, Preschool; Dexamethasone; Female; Glaucoma; Humans; Infant; Intraocular | 1982 |
Herpetic iridocyclitis.
Topics: Acyclovir; Administration, Topical; Adolescent; Adult; Female; Guanine; Humans; Idoxuridine; Intraoc | 1982 |
Acute ocular hypotony. A rare complication of temporal arteritis.
Topics: Aged; Eye Diseases; Female; Giant Cell Arteritis; Headache; Humans; Intraocular Pressure; Male; Pred | 1981 |
Drug effects on aqueous humor formation and pseudofacility in normal rabbit eyes.
Topics: Animals; Aqueous Humor; Atropine; Bradykinin; Dexamethasone; Dopamine; Intraocular Pressure; Melanoc | 1981 |
[The condition of the visual system in patients treated with excessive doses of Kenalog (author's transl)].
Topics: Adult; Aged; Female; Humans; Intraocular Pressure; Lens, Crystalline; Male; Middle Aged; Prednisolon | 1981 |
Steroid-induced ocular hypertension in the presence of a functioning Molteno seton.
Topics: Adolescent; Cataract Extraction; Female; Glaucoma; Humans; Intraocular Pressure; Lenses, Intraocular | 1995 |
Filtration surgery in rabbits treated with diclofenac or prednisolone acetate.
Topics: Animals; Combined Modality Therapy; Diclofenac; Endophthalmitis; Glaucoma; Intraocular Pressure; Pre | 1994 |
Ocular complications in renal transplant patients.
Topics: Adolescent; Adult; Aged; Cataract; Child; Child, Preschool; Cornea; Female; Graft Rejection; Humans; | 1994 |
Cyclodialysis cleft following a scleral tunnel incision.
Topics: Cataract Extraction; Ciliary Body; Female; Humans; Intraocular Pressure; Middle Aged; Ocular Hypoten | 1994 |
Clinical analysis of steroid glaucoma.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Dexamethasone; Female; Follow | 1995 |
Endocrine ophthalmopathy in a patient under continuous immunosuppressive therapy after cardiac transplantation.
Topics: Adult; Cyclosporine; Eye Diseases; Female; Graves Disease; Heart Transplantation; Humans; Immunosupp | 1995 |
Annular peripheral choroidal detachment simulating aqueous misdirection after glaucoma surgery.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Choroid Diseases; Drainage; Exudates and Transudates; | 1997 |
Increased intraocular pressure during treatment for chronic uveitis.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Chronic Disease; Dexamethas | 1997 |
Bilateral choroidal effusions and angle-closure glaucoma associated with human immunodeficiency virus infection.
Topics: Anterior Chamber; Atropine; Choroid Diseases; Ciliary Body; Exudates and Transudates; Eye Infections | 1997 |
Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs.
Topics: Administration, Topical; Anesthetics, Local; Animals; Anti-Inflammatory Agents; Aqueous Humor; Diclo | 1998 |
Anterior uveitis associated with latanoprost.
Topics: Administration, Topical; Adult; Aged; Female; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraoc | 1998 |
Glaucomatocyclitic crisis in a child.
Topics: Adolescent; Clonidine; Corneal Edema; Diagnosis, Differential; Drug Therapy, Combination; Glaucoma; | 1998 |
Change in intraocular pressure during long-term use of loteprednol etabonate.
Topics: Androstadienes; Anti-Inflammatory Agents; Clinical Trials as Topic; Humans; Hypersensitivity; Inflam | 1998 |
Pharmacological validation of a feline model of steroid-induced ocular hypertension.
Topics: Administration, Topical; Androstadienes; Animals; Cats; Dexamethasone; Disease Models, Animal; Femal | 1999 |
A pharmacoeconomic analysis of rimexolone for the treatment of ophthalmic inflammatory conditions.
Topics: Anti-Inflammatory Agents; Drug Costs; Eye Diseases; Health Care Costs; Intraocular Pressure; Managed | 1998 |
Uveitis associated with varicella virus vaccine.
Topics: Acyclovir; Adolescent; Anterior Eye Segment; Chickenpox Vaccine; Drug Therapy, Combination; Female; | 1999 |
Delayed, recurrent hypotonous maculopathy following aqueous suppressant therapy in pseudophakia.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma, A | 1999 |
Interface fluid after LASIK: misleading tonometry can lead to end-stage glaucoma.
Topics: Epithelium, Corneal; Exudates and Transudates; Glaucoma; Glucocorticoids; Humans; Intraocular Pressu | 2000 |
Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis.
Topics: Acanthosis Nigricans; Administration, Topical; Anti-Inflammatory Agents; Cataract; Child; Cushing Sy | 2000 |
Neovascular glaucoma as a complication of retinal vasculitis in Crohn disease.
Topics: Administration, Topical; Anti-Inflammatory Agents; Crohn Disease; Fluorescein Angiography; Fundus Oc | 2000 |
Uveitis and glaucoma.
Topics: Antihypertensive Agents; Cataract; Cataract Extraction; Cyclopentolate; Drug Therapy, Combination; F | 2000 |
Retinal periphlebitis as zoster sine herpete.
Topics: Acyclovir; Adult; Antiviral Agents; DNA, Viral; Female; Fluorescein Angiography; Genome, Viral; Herp | 2001 |
Progression to end-stage glaucoma after laser in situ keratomileusis.
Topics: Adult; Corneal Edema; Disease Progression; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; | 2002 |
Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma.
Topics: Acyclovir; Aged; Amides; Anti-Infective Agents; Anti-Inflammatory Agents; Antihypertensive Agents; A | 2002 |
Glaucoma implants. Their use in difficult cases of glaucoma.
Topics: Adult; Aged; Eye Diseases; Flufenamic Acid; Glaucoma; Humans; Intraocular Pressure; Intubation; Midd | 1978 |
Long term observation of ocular findings after renal transplantation.
Topics: Adolescent; Adult; Cataract; Child; Eye Diseases; Female; Humans; Intraocular Pressure; Kidney Trans | 1978 |
Steroid-induced glaucoma: A. Persistent elevation of intraocular pressure B. Histopathological aspects.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Conjunctivitis; Dexamethasone; Eczema; Female; Glaucoma; | 1977 |
[Effect of corticosteroids on hydrodynamics of the eye under experimental conditions].
Topics: Animals; Cortisone; Female; Hydrocortisone; Intraocular Pressure; Male; Prednisolone; Rabbits | 1978 |
A successful treatment for aphakic cystoid macular edema.
Topics: Aphakia; Humans; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ophthalmic Solutions | 1978 |
The effect of cation ionophores on intraocular pressure.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Aqueous Humor; Calcimycin; Dose-Response | 1976 |
Glucocorticoid responsiveness associated with HLA-B12.
Topics: Aged; Animals; Dexamethasone; Female; Glaucoma; Histocompatibility Antigens; HLA Antigens; Humans; I | 1977 |
[Electron microscopic studies on the angle of the anterior chamber in experimental steroid induced glaucoma in rabbit eye (authors transl)].
Topics: Animals; Anterior Chamber; Glaucoma; Intraocular Pressure; Prednisolone; Rabbits | 1977 |
Transient glaucoma as a manifestation of mumps. A case report.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adult; Follow-Up Studies; Glaucoma; Hu | 1976 |
In vitro corticosteroid: correlation response with primary open-angle glaucoma and ocular corticosteroid sensitivity.
Topics: Depression, Chemical; Dexamethasone; Dose-Response Relationship, Drug; Glaucoma; Humans; Hydrocortis | 1975 |
Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure.
Topics: Adrenal Cortex Hormones; Aged; Depression, Chemical; Dexamethasone; Dose-Response Relationship, Drug | 1975 |
Letter: Intraocular pressure rise.
Topics: Adrenal Cortex Hormones; Humans; In Vitro Techniques; Intraocular Pressure; Prednisolone | 1976 |
Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Cataract; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Female; Hu | 1992 |
[Anti-inflammatory treatment after argon laser trabeculoplasty].
Topics: Aged; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Endophth | 1991 |
Unusual deposits in the superficial corneal stroma following combined use of topical corticosteroid and beta-blocking medication.
Topics: Aged; Aged, 80 and over; Calcinosis; Calcium Phosphates; Cataract Extraction; Corneal Diseases; Corn | 1991 |
Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma.
Topics: Adult; Aged; Female; Fluorometholone; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Inflammatio | 1990 |
Communicating intravitreal cysticercosis.
Topics: Betamethasone; Cysticercosis; Humans; Intraocular Pressure; Male; Middle Aged; Neomycin; Prednisolon | 1989 |
Effect of indomethacin and prednisolone on the disruption of the blood-aqueous barrier after hyperthermia on the rabbit eye by focused ultrasound.
Topics: Animals; Aqueous Humor; Blood; Eye; Hyperthermia, Induced; Indomethacin; Intraocular Pressure; Predn | 1989 |
Progressive herpetic corneal endotheliitis.
Topics: Acyclovir; Administration, Topical; Adult; Antigens, Viral; Drug Therapy, Combination; Endothelium; | 1985 |
Three thousand YAG lasers in posterior capsulotomies: an analysis of complications and comparison to polishing and surgical discissions.
Topics: Acetazolamide; Cataract Extraction; Follow-Up Studies; Humans; Intraocular Pressure; Laser Therapy; | 1985 |
Secondary angle-closure glaucoma after central retinal vein occlusion.
Topics: Aged; Female; Fluorescein Angiography; Glaucoma; Humans; Intraocular Pressure; Male; Prednisolone; R | 1985 |
Pterional orbital decompression in progressive ophthalmopathy of Graves' disease. I. Short-term effects.
Topics: Adult; Aged; Antithyroid Agents; Cushing Syndrome; Diplopia; Edema; Exophthalmos; Eye Diseases; Fema | 1973 |
Histological and histochemical investigations on the effect of glucocorticoids on the trabecular meshwork in rabbit eyes.
Topics: Animals; Ciliary Body; Cortisone; Glucocorticoids; Glycosaminoglycans; Hydrocortisone; Intraocular P | 1969 |
[Endocrine exophthalmos].
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aged; Animals; Azathioprine | 1973 |
Treatment of a case of sympathetic ophthalmia.
Topics: Acetates; Anti-Inflammatory Agents; Antilymphocyte Serum; Azathioprine; Cataract; Child; Chlorambuci | 1974 |
Anterior ischaemic optic neuropathy. III. Treatment, prophylaxis, and differential diagnosis.
Topics: Acetazolamide; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Antihypertensive Agents; Arteri | 1974 |
The response of the rabbit eye to laser irradiation of the iris.
Topics: Animals; Aqueous Humor; Atropine; Blood Proteins; Ciliary Body; Constriction; Eye Injuries; Eye Prot | 1974 |
Iris involvement in leukaemia.
Topics: Acetazolamide; Atropine; Cerebrospinal Fluid; Child, Preschool; Eye Diseases; Female; Humans; Intrao | 1973 |
Annular serous detachment of the choroid.
Topics: Adult; Choroid; Diagnosis, Differential; Edema; Electrooculography; Eye Diseases; Female; Fluorescei | 1973 |
Raised intraocular tension in renal transplant recipients.
Topics: Acetazolamide; Adult; Echothiophate Iodide; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressur | 1973 |
Endothelial rejection in human transplants.
Topics: Adolescent; Adult; Aged; Cornea; Corneal Transplantation; Endothelium; Epithelium; Female; Glaucoma; | 1973 |
Ocular complications in renal transplant recipients.
Topics: Adolescent; Adult; Age Factors; Body Weight; Calcium; Cataract; Child; Creatinine; Evaluation Studie | 1973 |
[Congenital glaucoma and cortisone].
Topics: Administration, Topical; Anti-Inflammatory Agents; Conjunctivitis; Cortisone; Dexamethasone; Diagnos | 1973 |
Malignant optic nerve glioma. Report of a case with electron microscope study.
Topics: Astrocytoma; Endoplasmic Reticulum; Eye Foreign Bodies; Glaucoma; Glioma; Humans; Intraocular Pressu | 1973 |
An in vitro evaluation of tetrahydrotriamcinolone.
Topics: DNA; Dose-Response Relationship, Drug; Glaucoma; Humans; Intraocular Pressure; Lectins; Lymphocyte A | 1973 |
Dynamic tonometry. V. Further studies of the corneal indentation pulse in temporal arteritis.
Topics: Aged; Blood Sedimentation; Cornea; Embolism; Female; Giant Cell Arteritis; Humans; Intraocular Press | 1973 |
Increased cellular sensitivity to glucocorticoids in primary open-angle glaucoma.
Topics: Dexamethasone; DNA; Dose-Response Relationship, Drug; Glaucoma; Humans; In Vitro Techniques; Intraoc | 1972 |
[A case of glaucoma induced by short-term systemic steroid therapy].
Topics: Administration, Oral; Child; Female; Glaucoma; Humans; Intraocular Pressure; Prednisolone | 1971 |
[Steroid induced glaucoma].
Topics: Adult; Age Factors; Betamethasone; Child; Cortisone; Dexamethasone; Female; Glaucoma; Glucocorticoid | 1971 |
Steroid glaucoma.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Conjunctivitis; | 1965 |
[Pressure increase in local corticosteroid administration].
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Child; Cortisone; Dexamethasone; Fema | 1969 |
Effect of topical and systemic steroids on intra-ocular tension and aqueous outflow facility.
Topics: Adolescent; Adult; Aged; Aqueous Humor; Female; Glucocorticoids; Humans; Intraocular Pressure; Male; | 1969 |
Clinical investigations on the effect of glucocorticoids on intraocular tension.
Topics: Adolescent; Adult; Aged; Chorioretinitis; Humans; Intraocular Pressure; Middle Aged; Prednisolone; P | 1969 |
[Action of anti-inflammatory agents, corticosteroids and Tanderil, on intraocular pressure].
Topics: Adult; Aged; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Ointments; Ophthalmic Solutions; O | 1970 |
Fluorometholone. Anti-inflammatory and intraocular pressure effects.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Dexamethasone; Eye Diseases; Fluor | 1971 |
[Clinical studies on the effects of glucocorticoids on the intrabulbar pressure].
Topics: Adolescent; Adult; Aged; Humans; Intraocular Pressure; Middle Aged; Prednisolone; Prednisone; Tonome | 1969 |
["Steroid" glaucoma in a patient with pemphigus vulgaris during treatment with prednisolone].
Topics: Adult; Female; Glaucoma; Humans; Intraocular Pressure; Pemphigus; Pilocarpine; Prednisolone | 1965 |
[The effect of local steroid administration on intraocular pressure].
Topics: Adrenal Cortex Hormones; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Predniso | 1965 |
Krukenberg's spindles and primary open-angle glaucoma.
Topics: Administration, Topical; Adult; Aged; Anterior Chamber; Anti-Inflammatory Agents; Female; Glaucoma; | 1966 |